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Abstract
Neurological rehabilitation aims to reduce the restrictions on an individual’s 
participation in society. Psychometrically rigorous and clinically relevant 
outcome measures, used appropriately, enhance the evidence base of 
rehabilitation. This Thesis assesses routinely used outcome measures at 
three time points: inpatient, outpatient, and longer-term follow-up. First, a 
retrospective analysis of the inpatient database of the Neurorehabilitation 
Unit was carried out to assess the Barthel index (Bl) and Functional 
Independence Measure (FIM). Second, a prospective study examined the 
impact of rehabilitation on physical function and emotional wellbeing. Five 
measures were completed on admission, discharge and three months post­
discharge: the Bl (clinician and patient scored versions), FIM, General Health 
Questionnaire and Hospital Anxiety and Depression Scale. Finally, the effect 
of multiple sclerosis (MS) on work retention was assessed in a cross- 
sectional study using a newly developed outcome measure, the Impact on 
Work Questionnaire.
In the first study, the responsiveness of the Bl and FIM total scores ranged 
from moderate to large. But item level analyses indicated differential item 
performance, with effect sizes varying from very low to large, associated with 
large floor and ceiling effects. The second study demonstrated the significant 
improvements in physical and psychological functioning in patients 
undergoing rehabilitation. Physical gains persisted after discharge, however, 
emotional wellbeing deteriorated. The last study revealed that a combination
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of MS-related problems, environmental restrictions and poor vocational 
support impact on work retention in people with MS.
Following patients through the rehabilitation process, in the form of three 
distinct studies, has afforded a unique view of the effect of rehabilitation in 
neurological conditions. Furthermore, the examination of routinely used 
measures has provided guidance on the application of these in future 
research. Choosing the most appropriate measures and analytical 
techniques provides richer data, facilitates accurate evaluation of 
rehabilitation interventions, and ultimately improves patient care.
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Chapter 1 1ntroduction
Chapter 1 Introduction
1.1 Introduction to Neurological Rehabilitation
Neurological rehabilitation is an educational and problem solving approach 
for individuals with disabling neurological illnesses that enables them to 
achieve their optimum physical, psychological and social function. (Marks et 
al. 2000) It involves both active change by the individual who has become 
disabled to acquire the skills necessary to participate in society, and the use 
of resources to reduce societal barriers. (Rehabilitation Advisory Group NHS 
Executive 1997)
Neurological rehabilitation requires significant input from the patient as well 
as considerable healthcare resources; therefore, rehabilitation services must 
ensure that they are effective. To demonstrate effectiveness, it is necessary 
to measure the changes in patients’ health status as they journey from the 
onset of neurological illness, through rehabilitation, and onto reintegration 
into the community and resumption of their social roles. Measuring 
effectiveness improves the evidence base of neurological rehabilitation; but 
to detect clinically important change in patients, it is necessary to use 
responsive outcome measures. Furthermore, for neurological rehabilitation to 
be worthwhile, the changes made must endure after discharge as measured 
after reintegration into the community. And, after returning home, patients 
who wish to resume work must be able to do so; therefore the impact of 
neurological illness on work retention must be examined.
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The effect of rehabilitation can be measured at several levels -  impairment, 
activity and participation. To understand how these concepts have 
developed, this Chapter will explore the origins of neurological rehabilitation 
and how rehabilitation is currently practised in the Neurorehabilitation Unit 
(NRU) of the National Hospital for Neurology and Neurosurgery (NHNN), 
where the studies in this Thesis were undertaken. To demonstrate the 
established scientific background of outcome measurement and its relevance 
to healthcare, the history of outcome measurement will be reviewed with 
particular emphasis on how outcome measurement has become a key 
element in neurological rehabilitation. Finally in this Chapter, the studies that 
comprise this Thesis will be outlined.
1.1.1 History of Rehabilitation
Rehabilitation as a concept in medicine only came into existence in the late 
19th Century. Before this time, most patients who had been seriously injured, 
or who had sustained life-threatening illnesses, died. There are, however, 
some surprisingly modern examples of rehabilitation practice from antiquity. 
One illustration of this is a comprehensive therapeutic programme for the 
functional deficits due to stroke, developed by Caelius Aurelianus working in 
Rome around 400 AD. (Lippert-Gruner 2002) He proposed the use of 
individualised rehabilitation programmes focusing on the impairments caused 
by stroke including facial paralysis, dysphagia and mobility restrictions. He 
also describes for the first time a graded exercise programme. This
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programme progresses from walking with the assistance of two, through 
walking with aids, to walking unaided across uneven surfaces. Unfortunately, 
the comprehensive multidisciplinary team approach used by Caelius 
Aurelianus did not survive the fall of the Roman Empire and the subsequent 
Dark Ages in Europe.
With the improvements in healthcare in the latter half of the 19th century -  
organised nursing care, antisepsis and anaesthetics -  many more patients 
were surviving hitherto fatal illnesses. (Howat 2001) In particular, those 
injured during armed conflict were surviving injuries sustained during combat. 
With increasingly sophisticated weapons, it became necessary to employ 
larger armies. Two of the largest conflicts of the 19th century were the 
Crimean war (1853 -1856) and the American civil war (1861 -  1865). They 
resulted in casualties on a scale never encountered before. For instance, it 
has been estimated that 15,000 men lost a limb during the American Civil 
War. (O'Connor 1997) Paradoxically, the first modern style artificial limb was 
exhibited at the Crystal Palace Exhibition in 1851. One of the notable 
developments during the American Civil War was the Turner’s Lane Hospital. 
(Freemon 1993) Here Silas Mitchell developed a centre for the treatment of 
soldiers with neurological injuries. The three neurologists on the staff of the 
hospital studied and developed treatments for neuropathic pain and phantom 
limb pain, common symptoms in neurological rehabilitation practice still seen 
today. But the developments in treating these neurological injuries did not 
extend to the treatment of spinal cord injuries. In the mid-19th century,
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patients with cervical level injuries died within one week of injury and patients 
with lumbar level injuries succumbed within a month. (Silver 1993)
By the end of the 19th century progress had been made in the rehabilitation 
of patients with hemiplegia and aphasia following stroke. The mainstays of 
treatment at this point were intensive retraining and exercise. In 1856, Todd 
described the use of regular active or passive exercising of paralysed limbs 
to prevent contracture development. (Licht 1973) Towards the end of the 
century, Frenkel, at the Hopital Pttig-Salpdtr&re, developed the first hospital 
gymnasium to promote the principles of retraining after stroke. (Licht 1970) 
Charcot’s successor at the Salpgtr&re, Raymond, coined the phrase 
“reeducation des movements” for the service.
Apart from the examples mentioned above, very few rehabilitation facilities 
were in existence at the start of the First World War. The years 1914 to 1918 
left a legacy of an estimated 10 million disabled people amongst the nations 
involved in the conflict; 400,000 in Britain alone. (Koven 1994) This resulted 
in a huge need for services to cope with the needs of soldiers recently 
paralysed or with limb amputations. Robert Jones, an Army orthopaedic 
surgeon, lamented the lack of comprehensive physical therapy to ensure the 
success of his orthopaedic operations. His research into disability at the time 
focused on the person holistically and encouraged regular therapy to foster a 
sense of normality amongst ex-servicemen. (Buxton 1965)
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Vocational rehabilitation was extolled in the years after World War One by Sir 
William Osier who stated “there is no question of greater national importance 
than how to make these men again effective citizens, capable of earning 
their own living”. (Cited in Koven 1994) The need for diversions to occupy 
former soldiers led to the development of occupational therapy, a new 
discipline that utilised purposeful activity to facilitate rehabilitation. Its 
strategies had developed from the moral treatment movement of the late 
1800’s. Patients who were considered to be “mentally or muscularly flabby” 
were prescribed a period of training to restore their occupational ability. 
(Hanson and Walker 1992) The use of occupational treatments moved from 
being purely diversional, through being therapeutic, to being seen as an 
essential part of treatment to allow a person to reintegrate into their 
communities. The literature of the history of occupational therapy describes 
the progression from ex-servicemen making ashtrays from used bullets to a 
more comprehensive service within community hospitals where patients with 
disabilities were brought through a series of programmes from the “pre­
industrial shop” to proper work and in some cases into a new career.
(Gutman 1995; Gutman 1997) Interestingly, the founders of the discipline 
drew on Caelius Aurelianus’ earlier model of graded activity to remedy the 
deconditioning that occurred after disabling injury, building on the example of 
the rehabilitation of patients recovering from pulmonary tuberculosis in 
Germany. (Creighton 1993)
After the outbreak of World War Two, several strategies were put in place to 
co-ordinate the care of soldiers injured during combat. The first spinal cord
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injury centre in the Britain was established at Stoke-Mandeville in 1941. This 
unit’s management of spinal cord injury reduced the mortality rate of spinal 
cord injury which at the end of the 1930’s was still 80% within the first year. 
(Silver 1993) The same year, a brain injury unit was established in 
association with the Royal Infirmary in Edinburgh to care for soldiers with 
traumatic brain injuries. (Pentland et al. 1989) One of the founders of this 
unit, Oliver Zangwill, went on to develop a vocational rehabilitation service for 
patients with brain injury. Similarly, in the United States, the Air Force was 
the first of the Forces to develop a rehabilitation programme for its injured 
pilots in 1942. (Moss 1974) This was an integral part of the Air Force’s 
hospital services and was primarily responsible for returning pilots to active 
service. This situation was mirrored in Canada, where Botterell opened the 
first spinal cord injury unit in North America in 1945 to rehabilitate Canadian 
soldiers injured in the War and return them to a productive life. (Tator 1999)
Many physicians who returned from World War Two saw the need for 
services in the community similar to those that they had been providing to 
disabled soldiers. (Chamberlain 1992) A number of rehabilitation units were 
set up, particularly in the United Kingdom, in disused military hospitals, to 
provide a range of services for people with neurological injuries, amputations 
and rheumatological illnesses. Some of the principles of rehabilitation that 
had developed for patients with neurological injuries were applied in other 
medical fields for previously well patients who had became disabled through 
acute illness. For example, in cardiology, patients following acute myocardial 
infarction were prescribed eight weeks of bed rest. So called strenuous
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activities, such as climbing the stairs, were prohibited, often indefinitely. 
Needless to say, patients rarely returned to a normal lifestyle and never to 
employment. In 1951, the first post myocardial infarction rehabilitation 
programme was instituted and proven to be safe. (Pashkow 1993) Cardiac 
rehabilitation rapidly became an accepted treatment when it was shown that, 
not only was it not detrimental to patients’ health, but it actually reduced 
complications, such as pulmonary embolism.
By the 1970s most developed countries had a network of rehabilitation units 
that provided care for patients with a range of neurological and non- 
neurological illnesses. (Tunbridge 1972) These, in general, provided a 
multidisciplinary approach to the patient and were developing programmes of 
research into rehabilitation methods and outcome measurement. In order to 
standardise nomenclature between countries and to capture information 
about non-fatal health outcomes, the World Health Organisation developed 
the International Classification of Impairments, Disabilities and Handicaps 
(ICIDH). (World Health Organisation 1980) This classification was an attempt 
to gather data beyond the mortality statistics that had been collect by the 
International Statistical Classification of Disease and Related Health 
Problems (ICD). It was largely the result of work by Badley, Bury and Wood 
in Manchester, who were studying the epidemiology of disabling conditions, 
and who required a conceptual model to classify the impact of disabling 
illness on an individual. (Wood 1989) They suggested a linear model that 
links a pathological process to its clinical manifestations (impairments) that 
impact on an individual’s ability to perform tasks (disability), which then
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impede his or her functioning in society (handicap). The overall model is 
illustrated by a diagram showing one-way arrows linking impairment, 
disability and handicap (Figure 1).
Figure 1 International classification of impairments, disabilities and 
handicaps (World Health Organisation 1980)
Disease —► Impairment —► Disability —► Handicap
The ICIDH was proposed in 1975 along the lines of the long established ICD 
and eventually published for field trials in 1980. (De Kleijn-de Vrankrijker 
2003) It was initially taken up enthusiastically by rehabilitation professionals 
in developed countries. (Granger 1985) However, the underlying concept of 
a linear model from pathology through to handicap has been challenged. 
(Thuriaux 1995) How pathology contributes to impairment and subsequently 
causes disability and handicap is not a straightforward relationship and is 
dependent on how individuals interact with their environment. Although this 
was acknowledged in the commentary for the ICIDH, the role of personal and 
environmental factors in handicap were not recorded by the classification. 
(Ustun et al. 2003) This meant that the ICIDH could not record or measure 
the effect that social circumstances and the physical environment had on an 
individual. For instance, if an individual does not return home after a stroke, it
(intrinsic) (exteriorised) (objectified) (socialised)
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is not possible to record if that was due to the individual’s poor recovery or 
due to their home environment.
There are relatively strong relationships between pathology and impairment 
e.g. in stroke, the clinical classification can be based on territory of cerebral 
infarction. (Bamford et al. 1991) There may also be a relationship between 
pathology and disability. This is less well defined, however, and while there 
may be a relationship, for example, in multiple sclerosis between lesions 
demonstrated on magnetic resonance imaging and disability, (O'Riordan et 
al. 1998a) other lesions can be demonstrated that are asymptomatic. 
(O'Riordan etal. 1998b)
There is a more tenuous relationship between pathology and handicap, as 
the latter is affected by the individual’s interaction with his or her 
environment. Two examples illustrate this point. In rural Mexico, a disabled 
child is seen as evidence of the parents’ ability to care for an especially 
vulnerable infant and so confers status on the parents. (Groce 1999) 
Secondly, in an area of east Massachusetts, there is an unusually high 
prevalence of autosomal recessive deafness resulting in a high proportion of 
babies being born deaf. Everyone in the community, both hearing and deaf 
understands sign language, consequently the social consequences 
(handicap) of deafness in that community are minimal. (Schalick 2000)
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To overcome these drawbacks, a revised version of the classification was 
proposed: the International Classification of Functioning, Disability and 
Health (ICF). (World Health Organisation 2001) This was a further attempt to 
describe the experience of disability and its manifestations on an individual 
(Figure 2). It was developed in parallel, in numerous languages, and field- 
tested in 15 countries in an inclusive process, involving disability groups, 
professional bodies and non-governmental organisations. One key element 
was the move away from what was seen as the medical model bias of the 
ICIDH. According to this model, disability requires medical treatment by 
clinicians. (Engel 1977) The other end of the spectrum is the social model. 
This requires society to adapt to the requirements of even the most severely 
disabled individual. (Bickenbach et al. 1999) The ICF synthesises the useful 
elements of the two models, rather than opting for one of the extremes. In 
this regard it may be seen as a biopsychosocial model. (Ustun et al. 2003)
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Figure 2 international classification of functioning, disability and health 
(World Health Organisation 2001)
Body function
1
Health condition 
(disorder or disease)
Activities
1
Participation
t
Environment Personal factors
The ICF is based on a similar four-level stratagem to the ICIDH that 
classifies the effects of an illness at an organ level (pathology), within the 
body (impairment), by the individual’s ability to execute a task (activity) and 
the individual’s involvement in a life situation (participation). It does not just 
replace the words “disability and handicap” with “activity and participation”, 
but emphasises the individual’s role in society and position in the community 
as the benchmark against which recovery from an illness is judged.
The ICF allows rehabilitation to be operationalised as “a process of active 
change by which a person who has become disabled acquires the 
knowledge and skills needed for optimal physical, psychological and social 
functioning”. (Marks et al. 2000) This definition was originally proposed by 
McLellan who presented rehabilitation as an opportunity to provide 
information and advice, and to discuss problems, with people who are 
disabled and their carers. (McLellan 1992) Rehabilitation encourages people
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to use their knowledge and skills to bring themselves from a less able state 
to one in which they have improved the interaction with their personal 
environment, community and society in general, to a level with which they 
are more satisfied. This takes the meaning of rehabilitation further and 
removes it from its origins where “rehabilitation” was performed on patients 
who had become acutely disabled, generally through trauma, to a much 
more widely applicable philosophy where individuals guide their own 
progress from their current situation towards their desired end point. 
Neurological rehabilitation aims to assist individuals in reducing the 
limitations placed on their activities and participation in society by 
neurological illness.
The widening of the scope of neurological rehabilitation has allowed it to 
develop from dealing solely with static neurological conditions, such as 
complete spinal cord injury. Structured multidisciplinary rehabilitation 
programmes are now in place for neurological illnesses which tend towards 
recovery, such as stroke and traumatic brain injury, (Bohannon 1993) as well 
as illnesses whose natural history is to deteriorate, such as progressive 
multiple sclerosis and Parkinson’s Disease. (Freeman et al. 1997; Thompson 
and Playford 2001)
The organisation of neurological rehabilitation is also changing and more 
importance is being placed on working with individuals in the community and 
in their preferred environments, such as work or leisure. (Wade 2003)
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The evolution of neurological rehabilitation has taken place in the context of 
the changes in society and healthcare along with an increase in the self- 
determination of individuals that has occurred over time. This has resulted in 
an evidence-based, individually tailored approach to the patient with a 
neurological illness. It is within this framework that the current procedure for 
neurological rehabilitation will be examined.
1.1.2 The Rehabilitation Process
Patients present to the health service with a sudden illness, or following 
deterioration in their formerly stable health status, for which they seek an 
explanation and treatment. Initially, they go through a diagnostic process that 
aims to establish the underlying illness. This is essential to plan treatment in 
the light of the overall prognosis of the condition. Often medical or surgical 
treatments are used to arrest further decline or ameliorate symptoms. If 
these are unsuccessful or are only partially successful, then other means 
must be used to restore the patient’s functioning and autonomy in the 
community. (Cardol et al. 2002) At this point, the multidisciplinary 
neurological rehabilitation team assesses the patient to outline the 
impairments and limitations to their activities and participation. (British 
Society of Rehabilitation Medicine 2002)
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Assessment in rehabilitation is somewhat different to making the traditional 
medical diagnosis which concentrates on using patterns of impairments to 
establish the underlying pathology that is backed up with laboratory or 
radiological evidence. The goal of rehabilitation assessment is to acquire 
sufficient information to understand the cause of the presenting problem, 
develop a prognosis if appropriate, and plan specific interventions. (Wade 
2002a) In rehabilitation, the presenting problems will be limitations in activity 
or participation that have to be viewed in the context of the patient’s social 
and environmental circumstances.
In many ways rehabilitation assessment has a wider scope than making a 
medical diagnosis and relies on the multidisciplinary team’s breadth of skills 
to establish all of the areas that require addressing. (Johnson and Thompson 
1996) Individual team members may miss issues that are incorporated when 
the team works together, providing a more comprehensive overview of the 
patient’s potential to benefit from rehabilitation. (Cunningham et al. 2000)
The information collected is not just a means to an end. There is evidence 
that there may be a therapeutic benefit in the assessment procedure itself 
that highlights problems to the patient of which he or she may not have been 
aware and may then wish to address before formally entering a rehabilitation 
programme. (David et al. 1982) The assessment process is the first step on 
a journey that leads to a full understanding of the patient’s problems and the 
formulation of a treatment plan. (Wade 1998)
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The next step on that journey is the translation of the activity and 
participation issues into a set of realistic goals to be achieved during the 
rehabilitation programme. In this context, goals may be based around 
impairments, activities or participation. The long-term goal is the overall aim 
of the rehabilitation programme. This is supplemented by short-term goals 
that have a shorter time course and build on each other to guide the patient 
towards his or her long-term goal.
Many rehabilitation units use a goal-orientated approach to rehabilitation on 
the basis that setting a target focuses the staff and patient on achieving a 
common objective. (Schut and Stam 1994) Setting appropriate short- and 
long-term goals for a patient relies on a full and accurate assessment 
procedure that outlines the patient’s limitations in activities and participation. 
(McGrath and Davis 1992) It has been suggested that goals based around 
participation issues, for example, shopping, are preferable to those based on 
activities such as walking, balance or memory. (Wade 1999a) It is probably 
more meaningful for the patient to focus on participation restrictions as they 
have a greater immediacy and appropriateness to daily life for the patient in 
society. There is also evidence that setting goals at the participation level 
improves patient motivation as they are of greater relevance. (Schut and 
Stam 1994) Patient involvement in goal setting may improve rehabilitation 
outcome further. Participation of the patient in goal setting is fully compatible 
with the philosophy of rehabilitation and contributes to the patient’s 
autonomy. (Chan 2002)
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Goal achievement can be recorded in a number of ways. Goal attainment 
scaling assesses goal achievement by measuring the outcome of the goal 
against a preordained schema. (Rockwood etal. 1997) Goals are scored 
according to whether they are achieved, over achieved or under achieved. 
This allows goal achievement to be quantified and examined statistically as 
any other outcome measure. This technique does not, however, record why 
goals were not achieved. Recording goal achievement using an integrated 
care pathway (ICP) can allow analysis of goal components and the reasons 
why goals may not have been achieved. (Lowe 1998)
ICPs were initially introduced to promote quality and effectiveness in 
healthcare. (Lowe 1998) They were traditionally used in settings where care 
and treatment follows a well-defined pathway, for example, joint replacement 
surgery. (Aragon et al. 2002) It is increasingly recognised, however, that 
ICPs are able to facilitate the provision of multidisciplinary medical care to 
patients with complex needs. (Kitchiner et al. 1996) Use of ICPs has been 
shown to improve assessment and inter-team communication in acute 
stroke. (Sulch et al. 2002) They have been used to provide a framework for 
the rehabilitation process by describing the procedures that will be carried 
out during the patient’s stay, to record departures from that framework 
(variances) and to describe those variances. (Rossiter and Thompson 1995) 
They provide an opportunity for auditing the rehabilitation process as well as 
the outcome in terms of goal achievement. (Rossiter et al. 1998)
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Originally designed for use in hospitals, ICPs have been taken up by all 
healthcare sectors and have been used to set guidelines, monitor costs and 
improve communication between members of the multidisciplinary team. 
(Riley 1998) Standards now exist to develop ICPs that cross from acute 
hospital care, through rehabilitation and into community care, “integrated 
community pathways”. (Young et al. 2003)
An ICP is the integration of medical information, goal achievement and 
outcome measures within a document that is based on established 
guidelines and evidence-based practice. (Jackson et al. 2002) But for an ICP 
to be effective, the multidisciplinary team requires continuous education and 
training. (Newton 2003) ICPs are most effective, and have the highest rates 
of completion, when the multidisciplinary team has ownership over the 
development, introduction and evolution of the ICP. (Hassan etal. 2002)
Reassessment of the patient during the course of their programme allows the 
setting of new goals, the modification of treatments and the formulation of 
discharge plans, all of which is facilitated by the ICP. Reassessment is, of 
course, a key element in all medical procedures, but has become a sine qua 
non in rehabilitation. (Sinclair and Dickinson 1998) It is part of the 
standardised structured approach towards ameliorating a patient’s problems 
that is used by the multidisciplinary team to identify issues both at the 
assessment phase and during the journey through rehabilitation. (Wade 
2002b) This ability to respond to changes in the patient’s status means that
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both the team and the patient can remain focused on achieving the long-term 
goal.
Having an appropriate long-term goal to be achieved by discharge, which 
includes exploring options for return to work, allows the multidisciplinary 
team and patient to see beyond the discharge and towards the resumption of 
employment, education and social roles in the future. Some patients are able 
to return to these roles immediately after discharge from rehabilitation. 
However, others require the services of the outpatient therapy team or 
community rehabilitation team. (Hopman and Vemer2003; Sim et al. 1997) 
Vocational services, such as Jobcentre Plus or Rehab UK, working in 
combination with the rehabilitation team, can facilitate return to work if this is 
an element of the patient’s social role. (British Society of Rehabilitation 
Medicine 2000)
This section has described current practice of rehabilitation within the 
framework of the ICF. Rehabilitation allows the patient return to the 
community retaining the gains made during the inpatient phase of their 
programme and exploring options to return to full social interaction including 
education and employment as appropriate. The next section outlines how 
this process is applied in the neurological rehabilitation department where 
the studies described in this Thesis were conducted.
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1.1.3 The Neurorehabilitation Unit (NRU)
The NRU provides inpatient rehabilitation for adults with neurological 
illnesses. It is a constituent part of the hospital and the majority of patients 
admitted are referred by consultants from within the hospital. Patients are 
either admitted directly from neurological or neurosurgical wards (40%)1 or 
from home after being seen in outpatient clinics (49%). Eleven percent of 
patients are admitted from other hospitals.
The multidisciplinary team sees inpatient referrals on the ward, while the 
remainder is seen in the multidisciplinary clinic. During this assessment, the 
patient’s impairments, activity limitations and participation restrictions are 
noted and agreed upon by the members of the team. If it is felt that a transfer 
to the NRU is appropriate, rather than outpatient or community treatment, the 
main aims of the admission are discussed with the patient and, if acceptable, 
the patient is admitted.
Once in the NRU, a goal-orientated programme of rehabilitation is planned 
with a long-term goal and several short-term goals. Each patient has a 
keyworker who is a member of the multidisciplinary team. The keyworker is 
responsible for explaining the goals to the patient and ensuring that the 
patient understands and agrees with them. Goal setting is a relatively new 
technique in rehabilitation and perhaps because of this, the patient has not
1 Figures for 2002
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been fully incorporated into the goal setting process. A trial is under way in 
the NRU comparing the traditional way of goal setting with a collaborative 
method that asks the patient to identify and prioritise the participation issues 
that they feel are compromised by their illness. This information is then used 
as a basis for goal setting. Preliminary work suggests that this method is 
acceptable to patients and has identified areas of concern for the patient that 
might have been missed by the traditional approach.
The collaborative goal setting trial has been facilitated by the ICP that is used 
in the NRU, which incorporates the status of each goal set, as well as the 
outcome measures recorded for each patient. (Freeman et al. 1996) 
Originally, ICPs were developed for each of the three main diagnostic groups 
in the NRU, namely multiple sclerosis, stroke and spinal cord impairment. 
(Playford et al. 2002) These were recently combined to give a generic 
document that can be used with all patients. (Edwards et al. 2003) The 
outcome measurement information collected by the ICP is entered onto a 
database in the NRU and interrogation of this database has enabled two of 
the component studies of this Thesis.
1.2 Outcome Measurement
As outcome measurement is a key element in neurological rehabilitation, this 
section looks at its history from initial observational work to a discipline that 
can measure outcomes scientifically. The history of the science of
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measurement, psychometrics, will also be outlined. Finally in this section, the 
application of outcome measurement in neurological rehabilitation will be 
examined.
1.2.1 History
In keeping with the developments in neurological rehabilitation in the 20th 
Century, there has been recognition of the importance of recording the 
outcome of treatment. But, outcomes of medical therapy have always been a 
topic of interest to communities with medical practitioners. In ancient Egypt, 
the code of Hammurabi prescribed financial rewards for successfully treating 
patients. Inadequate outcomes were punished by physical and financial 
penalties depending on the severity of the mishap. (Schwartz and Lurie 
1990) Hippocrates encouraged those in his school to methodically report 
their outcomes, both successes and failures. Over the following centuries, 
however, medical progress became based on anecdotal observation. Not 
until the Renaissance, with the emphasis on experimentation and systematic 
observation, did scientific thought enter into medical decision making. James 
Lind performed the first investigative trial for a medical treatment in 1747 for 
the treatment of scurvy. (Bloom 1990) Even with evidence behind this 
medical treatment, it was nearly fifty years before the authorities took it up as 
a useful intervention.
In the 1800s mortality statistics were the primary outcome reported by 
hospitals, with no regard for the results of the operations and interventions
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that were performed within their institutions. Florence Nightingale, in her 
important 1863 treatise Notes on Hospitals, wrote, “if the function of a 
hospital were to kill the sick, statistical comparison of this nature would be 
admissible”, (lezzoni 1996) After returning from the Crimean War, she 
highlighted the importance of proper analysis of hospital activity in identifying 
the causes of inpatient mortality. Her work laid the foundations for nurse 
education and hospital design, both innovations leading to substantial 
decreases in inpatient mortality. (Cook 2002; Cook and Webb 2002)
At the start of the 20th Century, Ernest Codman was proposing the “end- 
result” system and he subsequently founded a hospital that bore this name. 
(Neuhauser 1990) He started the first systematic recall of patients to review 
how well treatment had resolved their complaint and what complications they 
had sustained. He was aided by Frank Gilbreth, who proposed “scientific 
management” in hospitals. Unfortunately, the hospital he founded failed after 
the First World War and Codman turned his energies to other issues, most 
notably setting up the first tumour register for sarcomas.
Evaluating outcomes became unfashionable in the years after Codman’s 
death. It re-emerged in the 1970s as medical interventions became more 
technical and commonplace and it was no longer such an ordeal to have 
surgery. Indeed it became the case that some surgery was done routinely, 
for example, tonsillectomies. The ethics and monetary consequences of 
routine surgery came into question and forced clinicians to base their
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treatments on the results of research and not anecdote. (Wennberg et al. 
1980)
At present there is significant emphasis on auditing the outcome of all 
aspects of medical care. Not just the end-result, but also the process by 
which it has been achieved. Audit is defined as “the systematic critical 
analysis of the quality of medical care, including diagnosis, treatment, 
outcome and quality of life for the patient”. (Department of Health 1989) All 
departments within hospitals and in the community are expected to regularly 
audit their practice, identify areas for improvement and implement change. 
(Wainwright et al. 1999) Several investigators have struck a note of caution. 
(Brook 1997; Davies 2001) They argue that while we are gathering data 
about the process of medical care, little is done to alter the deficiencies 
found. The essential part of using outcomes to improve care is to complete 
the “audit cycle” by examining the deficiencies noted, implementing changes 
and then re-examining the changes to see if they have resulted in the 
anticipated result. (National Institute for Clinical Evidence 2002; Turner- 
Stokes 2003; Gnanalingham et al. 2001)
However, there has been a trend away from evaluating the outcome of 
medical interventions by using data like mortality rates and lengths of stay. 
Similarly, biomedical measures such as clinical or laboratory indices do not 
provide a complete representation of the effect of treatment on an individual. 
These measures, while important in their own right, are being supplemented
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by measures of constructs that focus on issues of importance to the patient 
such as functional status, health related quality of life and emotional well­
being. (Fitzpatrick et al. 1998) A construct is a variable that is abstract rather 
than concrete, and is defined in terms of observed behaviour. Unlike 
concrete measures like blood pressure, it is more complex to measure 
constructs such as walking ability, depression or satisfaction with role. This 
requires the use of patient based outcome measures, where the patient 
gives his or her opinion on the construct in question. (Bergner and Rothman
1987)
With healthcare becoming more focused on outcome in the last 30 years, 
there has been increasing interest in seeking the patient’s opinion of his or 
her own health. Patient based outcome measures have been developed that 
allow patients to report their own health status. These outcome measures 
encompass a range of physical, psychological and social constructs that may 
be affected by illness. Measuring these constructs is a relatively new concept 
in healthcare, but has a long history in the social sciences.
Psychometrics as a science developed out of experimental psychology at the 
turn of the last century. There was a desire to measure constructs in the 
human experience such as intelligence, educational attainment or mood for 
which there were no objective measurement scales. It quickly became a 
fundamental part of educational psychology and the measurement of 
attitudes. (Thurstone 1928a) In the 1920s and 1930s a set of requirements
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for measures was developed, which formed the basis of modern outcome 
measurement. (Thurstone 1928b) This emphasised the need for measures of 
constructs, such as intelligence, that were linear, similar to the measurement 
of length or weight.
Thurstone’s method required the administration of a measurement scale to a 
large number of individuals for calibration. This was a time-consuming 
process and resulted in a scale that was only valid for the population for 
which the scale had been calibrated. (Streiner and Norman 1995) 
Subsequently, Likert, working with Gardner Murphy, developed measures of 
attitudes based on an individual giving their response to a set of adjectives 
on a rating scale from “strongly approve” to “strongly disapprove”. (Likert 
1932) This was subsequently taken up by healthcare researchers and widely 
used without the underlying proof that what was being measured was 
actually linear. In effect, this means that the distance between any two points 
on the scale may not be the same, for example, is the distance from 
“approve” to “strongly approve” the same as the distance from “disapprove” 
to “strongly disapprove”? Likert did not deal with this point in his original 
paper, and the debate over the importance of linearity has continued since. 
(Streiner and Norman 1995)
The science of psychometrics, or “classical” test theory, became an intrinsic 
part of educational and psychological evaluation in the 1950s. Classical test 
theory was extensively investigated and applied in these areas. (Massof
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2002) By this time, a number of leading psychometricians such as Louis 
Guttman, Frederic Lord and Georg Rasch had developed the next level of 
scale assessment. (Hambleton et al. 1991) This evolved into two areas of 
statistical method: item response theory and Rasch analysis. (Hobart 2002; 
Rasch 1966) These methods recognise that an individual’s response to an 
item in a measure represents some amount of the trait and then attempts to 
place those points into a linear relationship with other points.
Psychometrics came late to healthcare but has become widespread since 
the late 1970s with the development of numerous rating scales and patient 
based outcome measures, and the evaluation of older measurement 
instruments. (Hobart et al. 2001b) It is now recognised that in order to record 
a patient’s or clinician’s observations, one must use the principles of 
psychometrics to ensure that the construct is measured accurately.
1.2.2 Psychometric Principles
Outcome measures rely on being psychometrically sound to provide the best 
estimation of the construct being measured. The psychometric criteria for 
examining outcome measures have been developed and refined over the 
last fifty years and there is now a substantial body of work to refer to. 
Outcome measures are traditionally examined with regard to acceptability, 
reliability, validity and responsiveness. This section outlines these properties 
and how each contributes to the development of scientifically rigorous
39
outcome measures. Each of these properties builds on, and in some 
instances impacts upon, the previous properties. Where there is conflict 
between two or more properties, this is discussed under the relevant 
heading.
Acceptability: The first measure of acceptability of an instrument that must 
be made is whether it is acceptable to the individuals to which it is to be 
administered -  this has been termed “respondent burden”. Acceptable 
measures reduce potential distress in individuals who may be unwell and 
improve response rates in surveys. (Fitzpatrick etal. 1998) The Medical 
Outcomes Trust, an international, independent body responsible for 
promoting standards in outcome measurement, regards acceptability as one 
of the most important criteria in the selection of a measurement instrument. 
(Lohr et al. 1996)
Acceptability can encompass a number of aspects: the time burden, 
perceived relevance and perceived intrusiveness to patients. Acceptability 
can be measured by the length of time taken to complete the questionnaire; 
by a transitional question, asking the patient how he or she felt about 
answering the questionnaire; (Andresen et al. 1998) or by a structured 
interview carried out by the researcher after administering the measure. 
(Cheung et al. 2000)
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Respondents may also find instruments that have high content validity (see 
later) more acceptable and this can be enhanced by using questions 
developed from structured interviews of patients with the illness or condition 
so that acceptability is addressed at each stage of the design. (Hobart et al. 
2001a) This method reduces the possibility of designing questions that 
patients might find irrelevant, inappropriate, intrusive or offensive.
The second way of defining acceptability reflects the spread of the data 
recorded by the outcome measure in relation to the real spread of the data. 
(Ware, Jr. 1987) Ideally, the range of responses should match the range of 
the measure, with the mean of the responses at approximately the mid-point 
of the scale. (Testa and Simonson 1996) It can also be measured by the 
floor and ceiling effects (the proportion of patients who score each item at the 
lowest and highest points of the scale, respectively) and endorsement 
frequency tables (how many patients answer each of the items). Guidelines 
for floor and ceiling effects vary, but most authors would recommend that 
both should be less than 15% to 20% of items in the top and bottom 
endorsement categories. (Hobart et al. 2001a; McHorney et al. 1994)
Floor effects limit the ability of an outcome measure to detect change, as 
patients who score at the floor on their initial evaluation, may not change 
their score at follow-up, despite an improvement in their underlying clinical 
condition. For these patients, the extent of their change will be under- 
measured. (Ganiats et al. 1992) Conversely, patients who are already
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scoring at the ceiling of a measure at baseline cannot change their score 
irrespective of any further improvement. (Stucki et al. 1995b) For instance, 
an item in an outcome measure may rate patients as either dependent or 
independent in performing a task, such as walking. A patient with tetraplegia 
may change from being immobile to walking with standby assistance. 
However, on both occasions, this patient will be scored as dependent. The 
patient’s clinical improvement is not matched by an improvement in the 
outcome measure score. Therefore, changes outside the scale’s scope of 
measurement will not be detected. In effect, this means that the impact of an 
intervention could potentially be underestimated. Whilst scales are designed 
to minimise total score floor and ceiling effects, the impact of item floor and 
ceiling effects on a scale’s psychometric performance has not been 
examined. (Hobart et al. 2002; McHorney et al. 1994)
Reliability: Reliability is an estimate of the reproducibility and internal 
consistency of an outcome measure. (Fitzpatrick et al. 1998) A measure 
produces a total score that comprises the true score plus measurement 
error. (Bergner and Rothman 1987) The reliability coefficient represents the 
proportion of the total score that can be attributed to the true score. There 
are a number of reliability indices, including test-retest reliability, interrater 
reliability, intrarater reliability and internal consistency.
To be useful in a longitudinal study, a patient based outcome measure needs 
adequate test-retest reliability. This is the degree to which the measure is
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stable over time when no change is expected in the underlying condition. An 
interval of between two and 14 days is recommended between 
administrations of the measure. If the interval is longer, then the condition being 
measured may change. If the interval is shorter than two days, reliability may be 
overestimated due to a learning effect, that is, the respondent remembers 
the answers that he or she gave before, which introduces a bias. (Streiner 
and Norman 1995)
Test-retest scores can be evaluated in a number of ways. The most 
commonly used method is the intraclass correlation coefficient (ICC) which is 
calculated from the analysis of variance table (ANOVA). This is a statistical 
technique that determines the variance between the two administrations of 
the outcome measure. Whilst the ICC is commonly used in reliability studies, 
there is no set guideline for the level at which it should be set. Studies in the 
literature have used ICCs that range between 0.60 and 0.80 (Andresen et al. 
1996; Hobart etal. 2001a)
The second main way that test-retest results can be reported is by means of 
the Pearson correlation, which is a statistical technique based on regression 
analysis. It produces a statistic that measures how well a straight line can be 
fitted to the two sets of data. However, it may not detect if there is a 
systematic difference between the two sets of data. This tends to exaggerate 
the correlation between the two sets of data leading to spuriously high 
results. (Fitzpatrick et al. 1998; Streiner and Norman 1995)
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For clinician rated outcome measures, other aspects of reliability are tested, 
namely interrater reliability and intrarater reliability. Interrater reliability 
examines the error between different clinicians measuring the same patient 
at the same time. Intrarater reliability is analogous to test-retest reliability, 
and examines the error between two sets of measures performed by the 
same clinician rating a patient who is stable over time. The ICC is also 
preferentially used to express these indices at similar levels to the test-retest 
reliability index (0.60 to 0.80). (Unal et al. 2001) If individual clinical decisions 
are to be based on the outcome of the instrument then much higher interrater 
reliability should be sought; ideally the ICC should be greater than 0.95.
(Lohr et al. 1996) For example, if patients are to be discharged from a 
rehabilitation programme when they reach a certain level on a measure of 
ability, for example the Barthel index, then the clinician who is rating the 
patients must be able to demonstrate that he or she can score the Barthel 
index to a high level of intrarater reliability.
The final aspect of reliability, internal consistency, evaluates how closely the 
items that comprise a measure examine aspects of the same construct and 
not other constructs. Obtaining several estimates of the same construct by 
using a measure with a number of items ensures that the construct is 
accurately measured. (Bergner and Rothman 1987) This is, of course, only 
true when all items measure the same construct. Internal consistency
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coefficients estimate the extent to which the items measure the same
construct.
Internal consistency can be examined in a number of ways, most commonly 
by estimating Cronbach’s alpha for the items of the instrument. (Cronbach 
1951) Cronbach’s method divides a measure into two halves and examines 
the correlation between the responses to the items of both halves. 
Correlations are then examined for all possible divisions of the measure and 
an average of the correlations is found. The average correlation is reported 
as the alpha value. The values of this statistic should exceed alpha = 0.70 for 
measures that will be making comparisons between groups, for example, 
when comparing results from two groups in a study comparing different 
rehabilitation interventions. (Fitzpatrick etal. 1998) Higher internal 
consistency could suggest item redundancy (all the items asking the same 
question but phrased in different ways). However, for decision making in 
individual cases, for instance, deciding to start antidepressant treatment for a 
patient based on his or her responses to a measure of depression, the 
internal consistency should ideally be greater than alpha = 0.95. Higher 
internal consistency reduces the confidence interval around a score. Alpha 
values can be increased with a greater number of items in the measure, 
which decreases the confidence interval. (Riazi et al. 2002)
Internal consistency may also be estimated by the item-total correlation. 
(Streiner and Norman 1995) The item-total correlation examines the
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correlation between each item and the measure with the item removed. 
Correlations between the item and the remaining items of the measure 
should exceed r  = 0.20.
Validity: Reliability is essential, but not sufficient, to establish the validity of 
an outcome measure. Validity is an assessment of whether an instrument 
actually measures what it purports to measure. (Bergner and Rothman 1987) 
Validity, however, is not established for all potential uses of an instrument. 
Rather, it can only be said to be valid for the purposes for which it had 
originally been validated. For instance, the Rivermead mobility index is a 
valid measure of mobility for patients with neurological illnesses, but it is not 
valid for use in patients with musculoskeletal illnesses. (Ryall et al. 2003) As 
with reliability, there are a number of methods used to establish the validity of 
a measure. Traditionally, validity is tested under the headings of content, 
construct and criterion validity. (McDowell and Jenkinson 1996) Whilst 
appearing to be different properties of the measure, they all address the 
degree of confidence that can be placed in the results obtained from using a 
measure.
Content validity asks whether an instrument is appropriate to its use in a 
particular setting and can be determined by users of the scale or by a group 
expert in the subject matter of the scale. One such evaluation is the paper 
from the Department of Neurology, Leiden University, which reports on the 
content validity of four Parkinson’s disease scales. (Marinus et al. 2002) The
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four scales vary in their coverage of aspects of Parkinson’s disease. For 
instance, three of the four scales do not ask about transfers or dressing -  
aspects of ADLs that are commonly affected in Parkinson’s disease.
Similarly, only two of the scales have items relating to sexual relationships. 
However, the Parkinson’s impact scale (PIMS) has this item as an optional 
question as it remains unanswered in 32% of questionnaires. This example 
illustrates the interaction between acceptability and content validity.
Construct validity is a more quantitative measure of the validity of an 
outcome measure. An outcome measure is meant to evaluate a construct 
that is not directly observable such as ability or participation. This construct, 
however, can be expected to be related to other variables or outcome 
measures. Correlations can then be examined with the outcome measure 
under investigation against those relating to the construct in an hypothesised 
direction, magnitude and pattern. (McDowell an d  Jenkinson 1996) Construct 
validity postulates that the outcome measure w ill correlate more strongly with 
variables that are intuitively related to it (convergent validity) or correlate 
weakly with variables that are unrelated (discriminant validity). This is 
determined by calculating Pearson correlations between the outcome 
measures. There are a number of levels of correlation taken to demonstrate 
convergence or discrimination. Most authors use levels of correlation of r  > 
0.70 for convergence and r  < 0.30 for discrimination. (Hobart et al. 2001a; 
Tunis et al. 1999)
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Clinician rated scales can also be examined for construct validity. This 
technique was used to review the properties of the Barthel index, the 
Functional Independence Measure (FIM) and Functional Independence 
Measure + Functional Assessment Measure (FIM+FAM). These measures 
purport to measure physical and cognitive disability and very high Pearson’s 
correlation (r= 0.96 to r=  0.99) and agreement (ICC = 0.95 to 0.99) were 
found between them. (Hobart etal. 2001b)
Criterion validity is used when a measure is being compared to a well- 
established, “gold-standard” measure -  a criterion. This is form of validity is 
usually employed when developing a new measure where there is a criterion 
with which to compare it. However, in the development of outcome 
measures, there is rarely a criterion for constructs such as ability or 
participation, so criterion validity is not often reported. It assumes a role 
when a short version of a longer, more established measure is being 
developed. In this case, the longer measure is used as the criterion and 
Pearson correlations are again used to examine the relationship between the 
two measures. An example of this was the development of a 25-item version 
of the World Health Organisation Quality of Life assessment (WHOQOL) 
from a 100-item quality of life questionnaire. (World Health Organisation 
1998a)
It is important that instruments continue to be validated by use in different 
studies in different settings. Only by repeatedly using the instrument and
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confirming its validity in a number of settings with different samples can an 
instrument be said to be valid. It can be considered that a scale has not been 
“validated” in the original publication, but the evidence for its validity 
increases with each study in which it performs as expected. (Guyatt et al.
1993)
Responsiveness: Responsiveness is the ability of an instrument to detect 
accurately change when change has occurred. (Beaton et al. 2001) It has 
been termed responsiveness, sensitivity and sensitivity to change and 
authors have given each name a slightly different definition. It has also been 
argued that it forms part of the accumulation of evidence for the validity of a 
scale rather than a separate element establishing the psychometrics of an 
instrument. (Guyatt et al. 1989) However, as with all psychometric properties 
of a measure, responsiveness interacts with, and impacts upon, other 
properties. For instance, a measure with high test-retest reliability, that is, 
very stable across time, may not be very responsive.
There are numerous methods of reporting responsiveness. (Fitzpatrick et al. 
1998) These can be used to judge whether the instrument is effective at 
detecting change, what the magnitude of that effectiveness is, under what 
circumstances and in which sample. (Patrick and Chiang 2000) Liang defines 
sensitivity to change as the ability to measure change regardless of its 
relevance or meaningfulness to the patient or clinician, whereas he terms 
responsiveness as the ability to measure a clinically meaningful change.
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(Liang 2000) He recommends that all patient based outcome measures 
should have responsiveness established as a form of longitudinal construct 
validity. As with reliability and validity, responsiveness is a property of the 
instrument when used in a particular sample and needs to be re-established 
for each new use of the instrument.
The easiest method to examine responsiveness is to look at the change in 
score between baseline and follow-up (mean change score). This may then 
be examined by paired f-tests, assuming underlying normality. However, in 
very large samples a statistically significant difference can be generated 
without there being any clinically meaningful change in the patients. A 
method of overcoming this is to calculate the effect size (mean change score 
divided by the standard deviation of baseline score). This gives a magnitude 
and direction to the change expressed in units of standard deviation of the 
baseline score. (Kazis et al. 1989) In essence, the effect size statistic 
describes change as a function of the random variation in baseline scores in 
the sample. Thus, effect size is expressed in standardised units that 
facilitates comparison of different measures.
Cohen’s criteria are used categorise effect size results as small if less than 
0.20, moderate if approximately 0.50 and large if greater than 0.80. (Cohen
1988) These values were proposed empirically by Cohen to provide a 
quantitative expression of the magnitude and meaning of change brought 
about by an intervention. (Cohen 1992) Since publishing these criteria, they
have come into general use, firstly due to the inherent simplicity of 
calculating effect sizes, and secondly due to validation of the criteria by 
several studies. These studies have compared change, as measured by the 
effect size calculated from patient based outcome measures, with a transition 
question that rates change as perceived by the patient. The first study 
demonstrated concordance between patient satisfaction with lumbar spinal 
stenosis surgery, as measured by a transition question, and the 
responsiveness of a disease specific outcome measure. (Stucki et al. 1995a) 
The same group subsequently reported similar findings in a study of carpal 
tunnel syndrome surgery. (Bessette et al. 1998) In the Bessette et al study, 
patients’ opinion of their improvement (rated using a transition question) 
correlated closely with effect sizes calculated from a disease specific 
outcome measure. In a third study, of coronary revascularisation treatment, 
good concordance was found between a transition question and the 
magnitude of change as determined from a patient based outcome measure 
asking about the impact of heart failure. (Middel et al. 2001) These studies 
provide evidence that Cohen’s criteria, whilst initially developed empirically, 
are closely related to change as directly reported by patients. It must be 
noted that responsiveness is different to statistical significance. Whilst the 
results of a study may be statistically significant, they may not be clinically 
significant as determined by responsiveness statistics.
In summary, an outcome measure must meet minimum psychometric 
standards to ensure rigorous measurement. Measures must be acceptable to
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the patients to which they are administered, and must capture the full 
spectrum of patients’ responses. A measure must demonstrate internal 
consistency and reproducibility to predefined criteria, and it must measure 
what it purports to measure when compared to other instruments. Finally, 
when clinically significant change occurs, this should be detected by the 
measure.
1.2.3 Role in Rehabilitation
It is relatively straightforward to measure an impairment-based construct; for 
instance, the time taken by a patient to walk ten metres. Measuring how 
walking impacts on participation in the community may not involve any direct 
measure of walking at all, as limited ability to walk may impact on work or 
social roles, and a measure of these constructs would be more efficient at 
detecting any change brought about by rehabilitation.
Quantifying activity and participation has only come recently to neurological 
rehabilitation in comparison to the overall development of the speciality. This 
may be because clinicians feel that it is too complex to measure these 
constructs, or that interactions between patients and their environment 
confounds what should be measured in the individual patient. (Hobart 2002) 
The earliest measures in neurological rehabilitation focused largely on 
quantifying the impairments that a neurological illness produces, for example 
Kurtzke’s Disability Status Scale in multiple sclerosis. (Kurtzke 1955) One
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exception to this was the Barthel index, developed initially in 1955, to 
describe activity limitations in patients transferring from neurological 
rehabilitation units to nursing homes. (Mahoney and Barthel 1965) While 
these two measures were both developed during the mid-1950s and are still 
in common use, the Barthel index has superior measurement properties to 
the Disability Status Scale. (Hobart et al. 2000)
Since the adoption by healthcare researchers of psychometric principles 
there has been a substantial improvement in the quality of measurement in 
neurological rehabilitation. (McDowell and Jenkinson 1996) It is now possible 
to develop instruments that can accurately measure constructs such as 
functional status and emotional well being. (Guyatt etal. 1993) There are 
now well-established techniques to produce instruments that are based on 
issues of importance to patients as well as fulfilling a set of criteria that 
ensure sound measurement properties. (Lohr et al. 1996) An example of this 
is the development of a measure of the impact of multiple sclerosis that takes 
into account the patient’s perspective and uses psychometric methods to 
produce an instrument with superior measurement properties than the 
Disability Status Scale. (Hobart et al. 2001a) Further developments of these 
techniques and the use of more sophisticated methods of scale design and 
testing will enhance the ability of clinicians to measure the effect of 
neurological rehabilitation.
53
Combining psychometric methods with the ICF have allowed new ways of 
thinking about outcome measurement in neurological rehabilitation. (Tennant 
2000) The combination of these frameworks has facilitated the development 
of new instruments for measurement in neurological rehabilitation and the 
classification of existing instruments according to what they purport to 
measure.
As a rehabilitation programme is individually tailored to a patient’s needs, it 
presents difficulties if one wishes to document the changes effected over the 
course of the programme. It also makes comparing patients with the same 
illness difficult, as there is no criterion against which to compare change. 
Collecting data using outcome measures enables standardised information 
to be gathered on patients during the rehabilitation process. This information 
can be used to track changes in individual patients’ progress or within a 
group of patients with the same diagnosis. As well as these benefits, using 
standardised outcome measures allows comparison between patients at 
different times in the same unit, which facilitates clinical audit.
1.3 Types of Outcome Measures
Once an outcome measure is selected for use in a study or clinical setting 
that is appropriate, reliable, valid and responsive, one needs to consider the 
constructs and population that one intends to study. This section considers
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the main types of outcome measure that have been used in neurological 
rehabilitation studies and discusses their relative merits.
1.3.1 Generic
Generic health related quality of life measures are widely used and aim to 
capture information from a number of health related constructs such as 
physical, psychological and social functioning, mobility, daily activities, and 
pain. They can be used in both a general sample of patients and in patients 
with a particular illness. Examples of generic measures are the Medical 
Outcomes Trust Short Form 36-item questionnaire (SF-36) and the World 
Health Organisation Quality of Life Questionnaire (WHOQOL). (Ware, Jr. and 
Sherbourne 1992; World Health Organisation 1998b)
Generic measures are useful in the clinical setting when breadth of 
measurement is essential. They may not show good responsiveness in 
studies where a treatment is being investigated for the specific amelioration 
of a particular ailment, but they may indicate if there are other areas that 
need addressing due to side effects or other untoward problems with the 
treatment.
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1.3.2 Dimension Specific
These instruments attempt to measure an aspect of overall health status 
such as psychological wellbeing. The Hospital Anxiety and Depression Scale 
(HADS) is one such measure which taps these two dimensions of 
psychological status. (Zigmond and Snaith 1983) Dimension specific scales 
are used largely in psychological testing to capture data from a single 
construct. They allow in-depth reporting of the construct that they purport to 
measure e.g. anxiety or depression. This may affect their responsiveness, as 
they cannot capture other aspects of a condition that a treatment might be 
aiming to change.
1.3.3 Disease Specific
Disease specific measures aim to represent the spectrum of health related 
concerns associated with a particular disease or condition e.g. the Multiple 
Sclerosis Impact Scale 29-item (MSIS-29). (Hobart etal. 2001a) Being 
specific to the disease, it will appear more appropriate to patients. This will 
translate into a higher response rate when administered, as patients will see 
it as more relevant to their problems.
However, it is always possible that if disease specific measures are used 
exclusively, then one might miss an effect on constructs not measured by a 
disease specific instrument and only by the wider scope of a generic 
measure. This area has been explored by the European Consortium on
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Cancer Outcomes. (Sprangers et al. 1993) It has developed a measure that 
consists of a generic scale which covers the issues that might be common to 
all cancers and cancer treatments (e.g. fatigue, pain, nausea and vomiting) 
with disease-specific measures that are used with particular types of cancer. 
This approach of combining different types of outcome measures can be 
applied to any combination of existing measures to examine the patient’s 
perception of their health in one or more constructs.
1.4 Administration of Outcome Measures
After selecting a scientifically sound outcome measure that captures the 
construct or constructs of interest, it is necessary to administer it to patients. 
This will depend on the nature of the construct of interest, the educational 
level of the patients, the resources available and the design of the study. 
Outcome measures can be administered by self-report questionnaire, face- 
to-face or telephone interview, treatment diaries, computer-assisted 
questionnaires and more recently by electronic mail and Internet based 
methods. This section will explore some of these methods of administration, 
how they can be used to greatest effect and their advantages and 
disadvantages.
1.4.1 Postal Questionnaires
Mailed, self-report questionnaires are the mainstay of surveys. It is the 
cheapest method, can be administered from one central office, and does not
57
rely on trained interviewers. For example the cost of administering the SF-36 
by post is $27.07 per administration as compared to $47.86 by telephone. 
(Zaslavsky et al. 2002)
There are a number of issues relating to the use of this method. First is the 
non-response rate. This is possibly the most important point as it has long 
been established that non-responders are systematically different from those 
who do return questionnaires. (Brambilla and McKinlay 1987) For instance, 
in North America, older people, people with disabilities, Hispanic or black 
people and those with less education return questionnaires less frequently. 
(Zaslavsky et al. 2002) This will bias the results, particularly by omitting those 
people who may have different experiences of healthcare.
Good questionnaire design is the most important element in securing high 
response rates. (Dillman etal. 1993) Dillman has long been the proponent of 
proper questionnaire design to obtain the best response -  “The Total Design 
Method”. (Dillman 1978) Using the same style across pre- and post-mailing 
reminders and a “motivational” insert produces the best response rate. Other 
factors that increase response rates include personalising the posted items 
by using a covering note or an advance notification. (Eaden etal. 1999)
With postal questionnaires there is also the risk of item non-response even in 
those questionnaires returned. This reduces the usefulness of the
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information. To improve the completion rate one must carefully design the 
questionnaire to ensure ease of completion. One study looking at the SF-12 
in older people found that, by redesigning the stem and leaf configuration, 
the item response rate was significantly higher, with the added benefit of a 
reduction in the error rate in optical scanning due to patients selecting two 
responses for the same item. (Iglesias etal. 2001)
1.4.2 Telephone Interviewing
While telephone interviewing is more expensive than postal questionnaires, it 
still costs less than face-to-face interviewing and can be performed from a 
central office. However, it does require a trained interviewer, which increases 
expense. This improves the item response rate and allows the interviewer to 
explain items that the respondent may find difficult. (Nybo Andersen and 
Olsen 2002) Item response has also been shown to be higher to telephone 
interview, possibly by including people who are illiterate or who have visual 
impairment. (Harris et al. 1997)
The main disadvantage of telephone interviewing is not being able to contact 
people to have an adequate sample of the population under review. The 
most obvious set of respondents who will be left out are those who do not 
use the telephone because they are deaf. (Barnett and Franks 1999) 
However a potentially larger source of bias is the exclusion of people without 
telephones for social reasons. It has been demonstrated that people in this
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group are more likely to be smokers, take less exercise, participate less in 
health screening, have greater disability and are less likely to have health 
insurance. (Corey and Freeman 1990; Ford 1998; Marcus and Telesky 1983)
Of course, like postal questionnaires, it is possible that there are difficulties 
reaching some people. Only conducting interviews during office hours, for 
example, will exclude those working outside the home during the day. 
Techniques to improve response rate include arranging a time for the 
interview to be conducted and leaving a message on an answering machine 
if the respondent does not answer. (Harlow et al. 1993; Smith et al. 1995)
1.4.3 Face-to-Face Interviewing
Face-to-face interviewing is the most labour intensive and expensive method 
of obtaining patients’ opinions. However, it has the advantage of being the 
most personal and of providing the greatest assistance to the person being 
interviewed should they have difficulties understanding the questions. The 
interviewer can also travel to the person being interviewed which further 
reduces the inconvenience to the patient, as well as allowing the interviewer 
to be certain of the identity of the patient. (Frerichs and Shaheen 2001)
The nature of the face-to-face interview may affect what respondents report 
to interviewers. More impersonal methods like a questionnaire or telephone
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interview produce higher rates of reporting behaviourally sensitive issues 
such as alcohol consumption, drug use and use of seat restraints for 
children. (Corkrey and Parkinson 2002; Pless and Miller 1979) Similarly, 
patients with stroke report less disability when questioned by telephone than 
face-to-face, which needs to be borne in mind when designing studies. 
(Korner-Bitensky et al. 1994)
Hybrid techniques have been developed that combine two or more of the 
methods outlined above. They have increased levels of cost and complexity, 
but can improve response rates markedly. One combination, used 
commonly, is the “drop-off”. This is where initial demographic data is 
obtained from respondents and a questionnaire is then left with them to be 
either collected or posted back to a central location. (Salant and Dillman
1994)
1.5 Study Objectives
Neurological rehabilitation has developed into an evidence-based discipline 
that provides a patient-centred, tailored, treatment based on the framework 
of the IGF. For neurological rehabilitation to be effective, it should improve 
the patient’s functioning in terms of their activities and participation. Change 
in function is recorded by the use of outcome measures. Appropriate 
outcome measures and methods of administration can be used to facilitate 
measuring the effect of the neurological rehabilitation process. A combination 
of generic and dimension specific outcome measures will provide the widest
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coverage of the patient’s experience of their health and wellbeing following 
neurological illness.
The first objective of this study was to comprehensively evaluate the 
responsiveness of the outcome measures used in the NRU by examining 
their ability to detect change at an item level in patients with neurological 
illnesses undergoing rehabilitation. This first component of the study 
compared the performance of the clinician rated, generic outcome measures, 
the Barthel index and the FIM. It then examined their relative properties in 
three different neurological illnesses; multiple sclerosis, stroke and spinal 
cord impairment.
The second objective of this study was to prospectively examine the changes 
effected by neurological rehabilitation on patients’ physical function and 
psychological wellbeing using clinician rated and patient based outcome 
measures. This study used the Barthel index and FIM as well as the self- 
report Barthel index, the General Health Questionnaire (GHQ) and the 
HADS. These measures were administered to patients in the NRU on 
admission and discharge. This was followed by a postal questionnaire sent 
to patients three months after discharge. This component of the study 
included an examination of the psychometric properties of the measures.
The third objective of this study was to identify the health related, personal 
and environmental factors that impact on work retention in people with MS.
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For the last hundred years, return to work has been a key element in 
neurological rehabilitation. However, the needs of people with chronic 
neurological illnesses who are trying to remain in employment can be 
neglected. This study used the self-report Barthel index, the GHQ and a 
newly developed questionnaire about the impact of MS on ability to work, to 
evaluate the physical, psychological and vocational status of a cross-section 
of people with MS.
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Chapter 2 Responsiveness of the Barthel and FIM
2. Responsiveness of the Barthel index and Functional Independence 
Measure (FIM)
2.1 Introduction
As discussed in the opening Chapter of this Thesis, the measurement of 
treatment outcomes is an integral part of neurological rehabilitation, (Hobart 
et al. 2001b) and promotes the clinical effectiveness of rehabilitation 
programmes. (Intercollegiate Working Party for Stroke 1999) Outcome 
measurement is an integral part of the patient’s journey through the 
rehabilitation process in the NRU. Outcome measures are recorded on 
admission and discharge for all patients, and for the last 10 years have been 
entered into a database. This database has facilitated a retrospective 
evaluation of the psychometric properties of two widely used, clinician rated, 
generic outcome measures, the Barthel index and FIM. The evaluation of 
these measures is described in this Chapter.
For the information from outcome measures to be meaningful, the measures 
must be clinically relevant. That is, they must include items pertinent to 
neurological rehabilitation interventions, such as mobility, activities of daily 
living, and communication. But outcome measures must also be 
psychometrically sound. (McDowell and Jenkinson 1996; Aaronson et al. 
2002) All outcome measures are required to be acceptable, reliable and 
valid, and to be able to be used in an evaluative study, it is essential that 
they demonstrate responsiveness. (Guyatt et al. 1987; Stucki et al. 1995a)
As discussed in Chapter 1, these psychometric properties combine to
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produce a rigorous measure. Thus, the prerequisites for a responsive 
measure are that it is also acceptable, reliable and valid.
For outcome measures with multiple items, responsiveness is usually 
reported for the total score. The responsiveness statistic is, therefore, a 
synthesis of the responsiveness of the individual items. Whilst it is a 
convenient index, total score responsiveness can conceal potential item level 
problems that could limit the responsiveness of a measure. One of the main 
limitations to responsiveness results from item floor or ceiling effects. 
(Fitzpatrick et al. 1998)
The aim of this study was to determine whether item score changes are 
accurately represented by total score changes, and the impact that item floor 
and ceiling effects have on overall scale responsiveness, in the Barthel index 
and the FIM.
2.2 Methods
This section outlines the methods used in this study. The first part presents 
the sample from which the data were collected. This is followed by an 
appraisal of the outcome measures (Barthel index and FIM) used in the 
study. The discussion of each measure is supplemented by a summary of 
their relevant measurement properties. Lastly, the analyses that were 
performed on the data are described.
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2.2.1 Sample
Data were collected from patients admitted to the NRU, from May 1993 to 
March 2003. All patients with complete admission and discharge data and a 
length of stay greater than 10 days were included. A length of stay greater 
than 10 days was chosen as this is the minimum planned admission for a 
patient, and less than this a change would not be expected in a patient’s 
functional ability.
The Barthel index and FIM were scored by consensus of the multidisciplinary 
team based on the patients’ abilities during the admission and discharge 
weeks. The outcome measures were scored according to the instructions of 
the developers. (Wade and Collin 1988; Uniform Data System 1993)
2.2.2 Barthel index
The Barthel index is a clinician rated generic outcome measure that 
measures the ability of patients with neurological or musculoskeletal 
illnesses to care for themselves. (Mahoney and Barthel 1965) The Barthel 
index measures ten personal activities of daily living (ADLs). Two items are 
dichotomous, six items have three-point scales and two items have four-point 
scales (Table 2.1). The items are summated and the total score ranges from 
0 to 20. Higher values indicate better functioning. (Wade and Collin 1988)
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The psychometric properties of the Barthel index are summarised in the 
following section.
Acceptability: It is frequently mentioned in textbooks of neurological 
rehabilitation that the Barthel index is limited by poor acceptability, in terms 
of its floor and ceiling effects. (Wade 1992) But when used in inpatient 
neurological rehabilitation, this limitation reduces in importance. In this 
setting, mean admission scores are close to the mid-point of the range of the 
Barthel index, and floor and ceiling effects are minimal, (van der Putten et al. 
1999) However, when used in a community setting, its acceptability is 
hampered by significant floor and ceiling effects. (Kelly and Jessop 1996) In 
Kelly’s study of 30 patients attending an occupational rehabilitation 
programme, seven of the 10 items had ceiling effects greater than 75%.
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Table 2.1 Items of the Barthel index and FIM
Barthel index FIM
Item Order of Response Order of Response
items* options items options
Motor Items 
Self-care
Feeding 5 3 1 7
Grooming 3 2 2 7
Bathing 10 2 3 7
Dressing upper body 8 3 4 7
Dressing lower body 5 7
Toileting 4 3 6 7
Sphincter control
Bladder management 2 3 7 7
Bowel management 1 3 8 7
Transfers
Bed/chair transfer 6 4 9 7
Toilet transfer 10 7
Bath transfer 11 7
Mobility
Walking/wheelchair use 7 4 12 7
Stairs 9 3 13 7
Cognitive Items 
Communication
Comprehension 14 7
Expression 15 7
Social cognition
Social interaction 16 7
Problemsolving 17 7
Memory 18 7
*Order as they appear in the Barthel index
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Reliability: The reliability of the Barthel index has been examined in several 
studies. It demonstrates good internal consistency (Hobart et al. 2001b) and 
test-retest reliability when used to rate patients with restricted ability due to 
neurological conditions in a rehabilitation setting. (Green etal. 2001) High 
inter-rater reliability has been demonstrated between members of the 
rehabilitation multidisciplinary team when rating patients’ ability following 
stroke and traumatic brain injury. (Collin et al. 1988; D'Olhaberriague et al. 
1996; Roy etal. 1988)
Validity: The Barthel index demonstrates convergent validity with other 
measures of physical function when assessing stroke patients. (Schuling et 
al. 1993; Anderson et al. 1996; Post et al. 2002) Post’s study also reports 
discriminant validity of the Barthel index against measures of psychological 
function.
Responsiveness: Responsiveness of the Barthel index has only been 
reported in MS and stroke. For patients with MS in neurological rehabilitation 
the Barthel index has low to moderate responsiveness (effect size 0.37),
(van der Putten et al. 1999) but good responsiveness (effect size 0.95 to 1.2) 
for patients with stroke. (Hsueh et al. 2002; van Bennekom et al. 1996)
In summary, the Barthel index is an acceptable, reliable and valid measure 
for patients who have neurological disability impacting on their personal
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activities of daily living. It is moderately responsive in a rehabilitation setting. 
Item-level acceptability and responsiveness have not been reported.
2.2.3 FIM
The FIM, like the Barthel index, is a clinician rated generic outcome measure 
designed to collect information about patients in rehabilitation. It was 
developed because of the perceived limited responsiveness of the Barthel 
index. (Granger etal. 1986) The FIM comprises 18 items grouped into two 
domains -  motor (13 items) and cognitive (five items) (Table 2.1). Each item 
is scored on a seven-point scale; one represents complete dependence and 
seven represents full independence. A subtotal is generated for each domain 
and together the two domains give the total score. The motor scale is scored 
from 13 to 91 and the cognitive scale from five to 35. For each item and 
scale, higher values indicate better functioning. The literature regarding the 
psychometric properties of the FIM is examined in this section.
Acceptability: Floor and ceiling effects for the FIM motor and cognitive 
scales are less than 20% in patients with MS and stroke in neurological 
rehabilitation. (Brock et al. 2002; van der Putten et al. 1999) But in a study of 
patients with traumatic spinal cord injury admitted for rehabilitation, the motor 
scale had a floor effect of 61%, with a ceiling effect for the cognitive scale of 
93%. (Hall etal. 1999)
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Reliability: Internal consistency (Dodds etal. 1993) and intrarater and 
interrater reliability (Ottenbacher et al. 1996) were examined in two meta­
analyses of studies of patients with restricted ability due to neurological 
conditions in rehabilitation settings. Internal consistency was high, with 
Cronbach’s alpha of 0.93. Intrarater and interrater reliability, as measured by 
intraclass correlation coefficients were both found to be 0.95, when scored 
by members of the multidisciplinary team.
Validity: The FIM is reported to have the greatest content validity o f six 
measures purporting to measure disability. (Kelly and Jessop 1996) 
Convergent construct validity of the FIM is supported by strong correlations 
with other measures of physical function. (Sharrack etal. 1999) Discriminant 
validity has been demonstrated against measures of psychological function. 
(Freeman et al. 2000)
Responsiveness: The FIM motor scale has good responsiveness (effect 
size 0.91) in patients with stroke in rehabilitation, (van der Putten etal. 1999) 
However, a lower effect size (0.34) was seen in patients with MS. The FIM 
cognitive scale is moderately responsive in patients with stroke (0.61), but 
has negligible responsiveness in patients with MS. (Hobart etal. 2001b)
Low responsiveness of the cognitive scale can reduce the total score 
responsiveness. This is particularly true when improvements in the motor 
score influence the total score in patients with unchanged cognitive scores,
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for example, in patients with spinal cord injury. (Grimby et al. 1996) It has 
also been demonstrated that total scale responsiveness can mask low item 
level responsiveness. (Sharrack et al. 1999) This limitation can be overcome 
by reporting the responsiveness indices for the motor and cognitive scales 
separately.
The FIM, like the Barthel index, is a reliable and valid measure of a patient’s 
ability. It is appropriate for use in patients with stroke, MS and spinal cord 
injuries who are receiving rehabilitation. The motor scale appears to be very 
responsive but ceiling effects appear to hamper the cognitive scale. 
Responsiveness and acceptability have been demonstrated at scale level in 
patients in neurological rehabilitation. However, item responsiveness and 
item floor and ceiling effects have not been examined in this population, so 
the impact of these factors on the overall responsiveness of the measures 
has not been fully explored.
2.2.4 Analyses
Effect sizes were calculated for the total and item scores, for the group as a 
whole and for the diagnostic subgroups of MS, stroke and spinal cord 
impairment (SCI). (Kazis et al. 1989) These three groups make up the 
majority of patients treated in the NRU. Cohen’s criteria were used to 
categorise the effect size results as small if less than 0.20, moderate if 
approximately 0.50 and large if greater than 0.80. (Cohen 1992)
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Distributions of the total and scale scores, and each item’s response option 
frequencies were investigated using item endorsement frequencies. These 
are the percentages of patients endorsing each response option. It was 
expected that for each scale and item, the floor effect and ceiling effect 
effects should each be less than 20%. (McHorney et al. 1994)
2.3 Results
2.3.1 Sample
Out of 1495 patients admitted during the time period studied, 1390 patients 
(93%) had admissions of 10 days or longer and had complete admission and 
discharge data available (Table 2.2). Seventy-five percent of the total group 
comprised patients with MS (38%), stroke (20%) and SCI (17%). The mean 
age of patients was 48 years with a wide range of ages represented. Overall 
there were more females than males, which was largely due to the female 
preponderance in the MS group. The mean length of stay for the total group 
was 35 days. Patients with MS had shorter admissions than patients in the 
other groups. This is mainly because patients with MS are admitted from 
home for a defined rehabilitation programme, whereas patients with acute 
onset disability are admitted from other wards within the NHNN or other 
hospitals and require more extensive input before being discharged home.
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Table 2.2 Sample demographics
Total group MS Stroke SCI
Total number of patients 
Patients’ data available
1495 622 291 250
1390 569 282 236
Mean age (years) 
Standard deviation 
Range
48
15
44
12
53
15
52
16
1 6 -88  16 -75  1 6 -87  16-85
Sex (male/female) 
percent (male/female)
644/746 186/383 167/115 133/103
46/54 33/67 59/41 56/44
Mean length of stay (days) 
Standard deviation 
Range
35
24
23
10
51
30
43
27
10-184 10-102 10-149 10-184
2.3.2 Barthel Index
Total group: Admission and discharge Barthel index scores for the total 
group and the three disease groups, MS, stroke and SCI, are presented in 
Table 2.3. Effect sizes and floor and ceiling effects on admission and 
discharge are outlined for the Barthel index for the group as a whole (Table 
2.4).
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Table 2.3 Barthel index and FIM scores
Total group MS Stroke SCI
Admission Barthel index 
Mean (SD) 11.8(5.3) 12.2(5.4) 11.7(5.0) 11.2(5.3)
Range 0 - 2 0  0 - 2 0  0 - 2 0  0 - 2 0
Discharge Barthel index 
Mean (SD) 15.9(4.8) 14.8(5.4) 17.2(4.0) 16.3(4.2)
Range 0 - 2 0  0 - 2 0  2 - 2 0  3 - 2 0
Admission FIM Motor 
Mean (SD) 58.2(6.2) 59.7(19.4) 57.6(18.4) 56.6(19.6)
Range 13-91  13 -90  13-91 13 -88
Admission FIM Cognitive 
Mean (SD) 29.7 (6.2) 30.3 (5.2) 25.9 (7.5) 32.9 (4.2)
Range 5 - 3 5  10 -35  5 - 3 5  13 -35
Discharge FIM Motor 
Mean (SD) 72.7(17.5) 68.3(19.0) 77.2(14.7) 74.4(15.3)
Range 13-91  13-91 13-91 21-91
Discharge FIM Cognitive 
Mean (SD) 31.0(5.2) 31.0(4.8) 29.1 (5.8) 33.3(3.4)
Range 5 - 3 5  5 - 3 5  6 - 3 5  14 -35
Effect size for the Barthel index for the total group was 0.77. Total score floor 
and ceiling effects on admission were within the criterion value (1.2% and 
5.4%). On discharge, the floor effect was small (0.1%) but the ceiling effect 
exceeded the recommended value (27.8%).
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Table 2.4 Total group Barthel responsiveness and floor/ceiling effects
Effect size Floor/ceiling effect
Admission Discharge
Bowels 0.20 9.4/80.6 5.1/88.8
Bladder 0.33 20.4/60.6 10.3/76.8
Grooming 0.44 31.0/69.0 10.6/89.4
Toileting 0.51 22.0/46.5 10.4/74.9
Feeding 0.55 8.8/48.7 4.2/79.3
Transfer 0.59 8.5/39.5 3.4/72.9
Mobility 0.68 21.9/28.1 4.1/59.7
Dressing 0.64 22.6/34.6 7.6/67.6
Stairs 0.78 63.0/14.5 32.4/41.3
Bathing 0.80 78.0/22.0 45.1/54.8
Total 0.77 1.2/5.4 0.1/27.8
Item effect sizes ranged from 0.20 (bowels) to 0.80 (bathing). Admission item 
floor effects ranged from 8.5% (transfer) to 78.0% (bathing) with ceiling 
effects from 14.5% (stairs) to 80.6% (bowels). Discharge item floor effects 
were 3.4% (transfer) to 45.1% (bathing) and ceiling effects from 41.3% 
(stairs) to 89.4% (grooming).
Diagnostic groups: Effect sizes for the total scores (Tables 2.5a-c) were 
0.47 (MS), 1.09 (stroke) and 0.98 (SCI). Item effect sizes for MS ranged from 
0.13 (bowels) to 0.49 (bathing), for stroke from 0.18 (bowels) to 1.13 (stairs), 
and for SCI from 0.38 (feeding) to 1.16 (bathing).
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Table 2.5a Barthel responsiveness and floor/ceiling effects for MS
Effect size Floor/ceiling effect
Admission Discharge
Bowels 0.13 9.4/80.5 6.9/85.9
Bladder 0.30 23.3/49.7 16.4/67.4
Grooming 0.28 24.7/75.3 12.4/87.6
Toileting 0.26 21.6/54.9 14.9/69.5
Feeding 0.43 8.6/54.2 5.5/79.4
Transfer 0.38 10.2/43.0 6.5/64.9
Mobility 0.41 14.9/31.4 5.0/49.8
Dressing 0.38 19.3/41.8 10.2/61.4
Stairs 0.39 62.9/16.9 46.3/30.4
Bathing 0.49 73.5/26.5 51.8/48.2
Total 0.47 1.0/5.7 0.2/19.3
Table 2.5b Barthel responsiveness and floor/ceiling effects for stroke
Effect size Floor/ceiling effect
Admission Discharge
Bowels 0.18 5.3/90.4 1.8/95.4
Bladder 0.30 9.2/78.7 2.8/91.5
Grooming 0.70 44.7/55.3 9.6/90.4
Toileting 0.74 17.4/40.1 5.7/82.3
Feeding 1.11 6.7/19.9 2.8/71.6
Transfer 0.84 3.5/35.8 0.7/79.8
Mobility 0.88 33.0/29.1 3.9/71.3
Dressing 0.95 22.7/24.5 5.3/72.3
Stairs 1.13 56.4/15.6 14.2/57.8
Bathing 1.08 82.3/17.7 40.8/59.2
Total 1.09 0.7/5.3 0.0/40.1
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Table 2.5c Barthel responsiveness and floor/ceiling effects for SCI
Effect size Floor/ceiling effect
Admission Discharge
Bowels 0.40 17.7/64.6 7.6/85.7
Bladder 0.52 35.0/48.1 10.1/70.5
Grooming 0.42 23.6/76.4 5.9/94.1
Toileting 0.72 27.4/38.4 8.4/77.2
Feeding 0.38 5.9/71.3 1.7/89.5
Transfer 0.70 12.2/39.2 1.7/79.7
Mobility 0.89 18.6/23.2 1.3/61.6
Dressing 0.84 27.0/29.5 5.1/70.9
Stairs 1.08 73.4/9.7 31.2/38.4
Bathing 1.16 81.4/18.6 36.7/62.9
Total 0.98 2.515.5 0.0/24.1
Effect sizes for the total group and the diagnostic subgroups are compared in 
Figure 2.1. Again, overall, there was a similar pattern between items with 
effect sizes for items in the MS group being smaller than for the other two 
subgroups. One exception to the pattern was the feeding item, which was 
substantially higher (1.11) in the stroke group than for MS (0.43) and SCI 
(0.38).
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Figure 2.1 Barthel index item responsiveness
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2.3.3 FIM
Total group: Admission and discharge scores for the motor and cognitive 
scales of the FIM are presented in Table 2.3. Effect sizes and floor and 
ceiling effects are outlined in Table 2.6 for the total group.
The effect sizes for the motor, cognitive and total scales were 0.74, 0.22 and 
0.70 respectively. Floor and ceiling effects on admission and discharge for 
the motor and cognitive subscales and total scale were all less than 1.7%, 
except for the ceiling effect of the cognitive scale (28.5%, admission; 33.5%, 
discharge).
Item effect sizes ranged from 0.15 (problem solving) to 0.82 (walk/wheelchair 
use). For the items of both scales, there was a wide range in ceiling and floor 
effects at both time points. On admission the floor effect ranged from 1.0% 
(social interaction) to 60.1% (stairs) with ceiling effects from 1.1% (stairs) to 
66.1% (social interaction). Discharge floor and ceiling effects ranged from 
0.7% (memory) to 31.3% (stairs), and from 5.4% (stairs) to 76.4% (social 
interaction) respectively.
Diagnostic groups: Effect sizes for the three groups (Tables 2.7a-c) for the 
total scale were 0.42 (MS), 0.99 (stroke) and 0.86 (SCI). Item effect sizes for 
MS ranged from 0.09 (comprehension and problem solving) to 0.58 
(walk/wheelchair use), for stroke from 0.26 (bowels) to 1.05 (stairs), and for 
SCI from 0.04 (problem solving) to 1.03 (dressing lower body).
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Table 2.6 Total group FIM responsiveness and floor/ceiling effects
Effect size Floor/ceiling effects
Admission Discharge
Feeding 0.42 6.3/36.5 2.1/54.8
Grooming 0.43 4.8/41.2 2.4/64.2
Bathing 0.60 9.2/14.6 3.7/38.1
Dressing upper body 0.49 6.8/30.3 2.9/53.5
Dressing lower body 0.67 21.5/8.0 10.8/28.7
Toileting 0.52 16.8/21.4 8.8/46.7
Bladder 0.31 12.7/35.3 6.2/45.2
Bowels 0.24 7.0/37.0 4.4/51.2
Bed transfer 0.67 11.9/13.7 4.7/44.7
Toilet transfer 0.63 12.3/9.5 5.6/33.3
Bath transfer 0.72 21.8/2.6 8.0/10.4
Walk/wheelchair use 0.82 30.9/3.8 5.2/16.6
Stairs 0.76 60.1/1.1 31.3/5.4
Total motor 0.74 0.9/0.4 0.3/1.7
Comprehension 0.17 0.6/67.4 0.2/73.6
Expression 0.21 2.9/61.5 0.6/70.4
Social interaction 0.20 1.0/66.1 0.5/76.4
Problem solving 0.15 4.0/37.3 1.9/40.3
Memory 0.17 2.0/59.0 0.7/65.9
Total cognitive 0.22 0.2/28.5 0.1/33.5
Total 0.70 0.010.0 0.0/0.6
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Table 2.7a FIM responsiveness and floor/ceiling effect for MS
Effect size Floor/ceiling effect
Admission Discharge
Feeding 0.32 6.3/39.7 2.8/53.8
Grooming 0.25 4.0/46.4 3.5/62.2
Bathing 0.31 8.4/17.0 6.0/31.2
Dressing upper body 0.26 6.2/33.2 4.7/48.3
Dressing lower body 0.34 22.3/8.4 15.9/19.8
Toileting 0.24 15.8/21.6 13.0/35.0
Bladder 0.27 15.1/19.9 9.6/23.3
Bowels 0.14 7.7/34.1 6.3/41.1
Bed transfer 0.42 15.1/11.1 9.3/29.6
Toilet transfer 0.38 15.8/6.3 10.0/19.6
Bath transfer 0.45 22.3/1.4 12.3/5.1
Walk/wheelchair use 0.58 22.3/1.8 5.6/6.1
Stairs 0.40 59.4/0.2 44.4/1.9
Total motor 0.44 0.5/0.0 0.4/0.2
Comprehension 0.09 0.0/71.9 0.2/75.5
Expression 0.12 0.0/69.4 0.2/75.3
Social interaction 0.15 0.4/69.6 0.4/78.5
Problem solving 0.09 3.2/31.6 1.8/33.1
Memory 0.10 1.6/52.5 1.1/56.9
Total cognitive 0.14 0.0/22.7 0.2/27.0
Total 0.42 0.0/0.0 0.0/0.2
Table 2.7b FIM responsiveness and floor/ceiling effect for stroke
Effect size Floor/ceiling effect
Admission Discharge
Feeding 0.72 5.7/13.4 1.4/36.7
Grooming 0.76 3.2/21.9 0.7/58.7
Bathing 0.94 7.8/9.5 1.4/41.3
Dressing upper body 0.89 5.3/15.9 0.7/47.3
Dressing lower body 1.05 16.6/8.5 4.6/35.5
Toileting 0.80 9.9/20.8 3.9/61.8
Bladder 0.30 8.1/58.0 2.8/73.9
Bowels 0.26 2.8/51.9 1.4/72.8
Bed transfer 0.93 7.1/18.0 1.8/62.5
Toilet transfer 0.88 7.1/15.9 2.1/52.3
Bath transfer 0.92 19.4/4.9 4.2/14.1
Walk/wheelchair use 1.03 37.1/8.1 3.9/30.7
Stairs 1.05 53.4/3.9 13.4/11.7
Total motor 1.04 0.4/1.4 0.4/3.2
Comprehension 0.33 2.8/42.4 0.4/51.9
Expression 0.36 11.3/32.2 1.8/46.6
Social interaction 0.34 1.8/47.7 0.7/65.7
Problem solving 0.32 6.7/18.0 2.1/24.7
Memory 0.33 3.9/44.9 0.0/55.8
Total cognitive 0.42 0.7/11.3 0.0/16.6
Total 0.99 0.0/0.0 0.0/0.4
Table 2.7c FIM responsiveness and floor/ceiling effect for SCI
Effect size Floor/ceiling effect
Admission Discharge
Feeding 0.34 4.2/61.0 0.0/73.7
Grooming 0.41 5.5/58.1 1.7/74.2
Bathing 0.77 10.2/13.1 2.1/43.2
Dressing upper body 0.49 11.0/42.4 2.5/64.4
Dressing lower body 0.92 23.3/5.1 8.1/31.8
Toileting 0.67 22.5/20.3 6.8/46.2
Bladder 0.46 16.5/22.0 4.2/34.7
Bowels 0.44 13.6/17.4 5.5/37.3
Bed transfer 0.80 13.1/14.0 1.3/51.3
Toilet transfer 0.75 13.6/7.6 3.0/34.3
Bath transfer 0.86 24.2/1.7 6.4/8.9
Walk/wheelchair use 0.94 40.3/3.0 5.9/13.6
Stairs 1.11 71.6/0.8 29.2/3.8
Total motor 0.90 1.7/0.0 0.0/0.4
Comprehension 0.13 0.0/84.7 0.0/90.3
Expression 0.11 0.4/87.7 0.0/89.8
Social interaction 0.07 0.4/83.5 0.0/87.7
Problem solving 0.04 1.7/66.4 0.8/66.9
Memory 0.14 0.9/85.1 0.0/90.7
Total cognitive 0.11 0.0/60.9 0.0/62.3
Total 0.86 0.0/0.0 0.0/0.4
Effect sizes for the FIM for the total group and the diagnostic subgroups are 
compared in Figure 2.2. As with the Barthel index there was a similar pattern 
between items, with effect sizes for items in the MS group being smaller than 
for the other two subgroups. Again the noticeable exception in the motor 
scale was the feeding item which was higher (0.72) in the stroke group than 
for MS (0.32) and SCI (0.34). The effect sizes of the cognitive items for the 
MS and SCI groups were all small (less than 0.15) whereas the stroke group 
had values in the range 0.32 to 0.36.
Figure 2.2 FIM item responsiveness
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2.4 Discussion
2.4.1 Summary of Results
The results of this study indicate that, in neurological rehabilitation, the 
responsiveness of the Barthel index, as measured by the effect size statistic, 
is moderate to large. Total score floor and ceiling effects are small. 
Responsiveness varies between groups, with the stroke group having the 
largest value, demonstrating that responsiveness is a sample dependent 
property. These results indicate that the Barthel index should have the ability 
to detect clinically important change in patients in rehabilitation, according to 
Cohen’s criteria.
The total score effect sizes for the Barthel index and the FIM motor and FIM 
total scores are comparable in magnitude. As seen with the Barthel index, 
responsiveness is greater in the stroke and SCI groups as compared to the 
MS group. The responsiveness of the FIM cognitive scale is low in the total 
group and in the MS and SCI groups. Only in the stroke group does the 
cognitive scale tend towards moderate responsiveness. Floor and ceiling 
effects of the FIM are minimal, apart from the ceiling effect of the cognitive 
scale. These results indicate that the FIM motor scale, like the Barthel index, 
should have good potential to measure change, but that the FIM cognitive 
scale would have poor potential in this regard.
The results of this study are comparable to findings reported by previous 
authors, including work from this department, (van der Putten et al. 1999; 
Hsueh et al. 2002) Effect sizes for the Barthel index and FIM in this study 
were of the same magnitude as those reported by other authors. (Hobart et 
al. 2001b) Patients in these three studies by other authors had similar 
demographics and lengths of stay to the patients reported in this study.
Analysis of the items suggests that the scales may not be as responsive as 
implied by the total score. The effect sizes of the items in both scales varied 
widely, indicating that some items detected more change than others. Effect 
sizes of the FIM cognitive scale were uniformly low, apart from the stroke 
group where they were low to moderate. FIM item responsiveness has 
previously been reported for patients with MS attending an MS outpatient 
clinic. (Sharrack etal. 1999) In Sharrack’s study, however, responsiveness 
was calculated only for 25 out of the 50 patients in the study who were 
judged to have changed since their previous visit. Item responsiveness in 
Sharrack’s study was similar to that found in this study.
This variation in item responsiveness can be explained, in part, by examining 
the items’ response option frequencies. Items with ceiling effects on 
admission imply that the patient cannot improve any further in that construct 
irrespective of any clinical improvement. Discharge item ceiling effects, which 
for all items in both scales were even higher than on admission, signify that 
patients may have improved more than the items measured. For example, in
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the item analysis of the Barthel index, the bowel item was the least 
responsive (0.20) and had the highest admission and discharge ceiling 
effects, 80.6% and 88.8% respectively. In contrast, the bathing item had 
good responsiveness (0.80) and relatively smaller ceiling effects, 22.0% and 
54.8% respectively, although these are still above recommended criteria.
This is the first study to evaluate item responsiveness and acceptability in 
patients undergoing inpatient neurological rehabilitation. The study 
demonstrates that total score analysis can be a limited indicator of the 
potential of an outcome measure to detect clinical change. The examination 
of item level responsiveness has revealed items within the measure that 
have poor responsiveness, which do not contribute to the measures’ overall 
responsiveness.
2.4.2 Study Strengths and Limitations
This study included all patients admitted to a neurological rehabilitation unit 
over a 10-year period who had completed at least 10 days of inpatient 
rehabilitation and for whom admission and discharge results were available. 
A high percentage (93%) of patients satisfied these criteria. The study 
sample comprised a range of patients with acute and chronic neurological 
illnesses. There was a wide age range, and male and female patients were 
represented in proportions appropriate to disease group. These results 
support the generalisability of the findings of this study.
The generalisability of these results is, however, limited by the extent to 
which the patients and the rehabilitation interventions delivered in the NRU 
are comparable to other rehabilitation centres. The patients in this study 
have similar levels of physical ability to those in other studies. (Nyein et al. 
1999; Post et al. 2002; Tow and Kong 1998) Other studies have included 
patients with less physical ability (Hsueh et al. 2002; Paolucci et al. 2000; 
Scivoletto et al. 2003) and greater physical ability. (Craig et al. 2003; 
McPherson and Pentland 1997; Salbach et al. 2001) None of these studies 
reports effect sizes for the Barthel index or FIM, so it is not possible to 
directly compare results. Only one, a study of patients with SCI admitted for 
rehabilitation, reports the Barthel index mean change score and standard 
deviation. (Scivoletto et al. 2003) The effect size for the Barthel index in 
Scivoletto’s study was 1.17, which is of a similar magnitude to the effect size 
for patients with SCI in this study (0.98).
Whilst the physical ability of patients in this study is comparable to patients in 
some of the other studies, there is less comparability with respect to 
cognition. Some studies of rehabilitation in MS and stroke describe patients 
with similar levels of cognitive ability. (Marolf et al. 1996; Ravaud et al. 1999) 
But most studies of patients with stroke and MS comprise patients with lower 
FIM cognitive scores. (Brosseau and Wolfson 1994; Fiedler et al. 2000; 
Stineman et al. 1996) In general, patients with severe cognitive impairments 
are not admitted to the NRU; therefore the patients in this study are not 
representative of the full spectrum of patients with neurological illness.
The Barthel index and FIM are both clinician rated outcome measures. This 
study did not take into account the patients’ opinion of the impact of 
rehabilitation -  either their opinion of the changes in physical function or the 
changes in emotional wellbeing. Therefore, it is not possible to determine 
from these analyses how much change occurred outside the measurement 
ability of these scales. This could have been achieved by the use of an 
appropriate transition question.
Finally, this study did not examine other psychometric properties of the 
Barthel index and FIM in this sample. It was not possible to examine the test- 
retest or interrater reliability of the scores in the NRU database. Therefore, 
the possibility that poor reliability of the scores could have reduced the 
responsiveness of the measures cannot be discounted. This possibility is, 
however, small as the reliability of these measures has been demonstrated 
in studies, both in the NRU (Hobart et al. 1996a) and in other centres. 
(Loewen and Anderson 1988; Roy et al. 1988)
2.4.3 Implications for Clinical Practice
The results of this study have two main implications for the clinical practice of 
neurological rehabilitation. Firstly, outcome measure responsiveness and 
treatment effectiveness are closely related. Secondly, the range of 
measurement of an outcome measure must match the range of the construct 
to be measured in a sample.
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The relationship between responsiveness and the impact of treatment can be 
illustrated by two examples. First, an item might measure a construct that 
would not be expected to change, as the patient has no deficit in that area, 
for instance, the low responsiveness of the cognitive items seen in patients 
with SCI. These patients generally have impairments isolated to the spinal 
cord and would not be expected to have cognitive deficits. Consequently 
changes would not be expected across these items.
Second, an item might reflect a construct that is unchangeable (rehabilitation 
is unable to modify it) or the instrument does not measure that change. For 
instance, a patient may have an indwelling urinary catheter on admission to 
the NRU that he or she is able to manage independently. During the course 
of the admission, the patient successfully starts using intermittent self- 
catheterisation, which is a preferable technique for bladder management. 
However, the bladder item in the FIM will remain unchanged as the patient 
continues to require a catheter to manage his or her bladder. No change is 
recorded by that item, so its responsiveness is poor.
These examples demonstrate the importance of matching outcome 
measures to samples. Using generic measures to detect clinical change 
inevitably means that there will be items that are not applicable to all 
patients. This is illustrated by the low responsiveness of the Barthel index 
and FIM in patients with MS. This does not necessarily mean that 
rehabilitation for MS is inappropriate, or that it is less effective than
rehabilitation for other conditions, merely that the Barthel index and FIM do 
not adequately detect the clinical change made by patients with MS in 
rehabilitation. Of course, responsiveness of the Barthel index and FIM refers 
only to the changes as measured by the multidisciplinary team recording 
changes from admission to discharge. These measures do not take into 
account the opinion of the patients in rehabilitation. Therefore, it may be 
more appropriate to choose an outcome measure that has been shown to be 
responsive for patients with MS in rehabilitation, such as the MSIS-29, which 
also takes the patients’ opinions into account. (Riazi et al. 2003) This issue is 
of importance, for instance, when conducting a trial comparing rehabilitation 
interventions. As responsiveness is the ability to detect clinically significant 
change, rather than statistically significant change, using responsive 
measures in trials improves the evidence base for rehabilitation 
interventions.
The item floor and ceiling effects noted in this study indicate the extent to 
which the Barthel index and FIM do not measure the full range of physical 
and cognitive ability of patients in the NRU. For the Barthel index, items have 
two, three or four response options. This is less than recommended by 
standard texts on outcome measure development. (Streiner and Norman 
1995) It is suggested that items should have seven response options to 
optimise discrimination between levels of ability. (Miller 1956) Items should 
also have a range of measurement that matches the range of the construct 
that is to be measured.
Floor and ceiling effects cannot be eliminated, but they can be minimised by 
appropriate item response options. Calculating floor and ceiling effects for 
the items of the Barthel index is an artificial procedure, as by implication, 
even if equal numbers of patients endorse each of the response options, 
there will be more than 20% of patients endorsing each response option. It 
does, however, illustrate the need for items to have response option scales 
that match the range of the constructs they purport to measure, from 
severely limited to no limitation, with clinically appropriate points in between.
The FIM is comprised of items that have the “magical number” of seven 
response options. Why, then, do the items of the FIM have such variable 
responsiveness? The answer lies in the difficulty of the response options for 
the items. Some items, such as stair climbing, which have large effect sizes, 
also have low admission mean scores. Patients can make substantial gains 
in these items by moving up the lower response options. To gain the higher 
response options (six and seven) requires more improvement than is 
necessary to gain lower response options. The FIM, like the Barthel index, is 
an ordinal scale with a fixed scoring system that is criterion-based. Point 
differences between individual response options are not the same and 
changes at the lower end of the scale occur much more easily than at the 
upper end. (Linacre et al. 1994) Again, this emphasises the need to write 
appropriate response options for items.
In summary, it is important to choose an outcome measure that matches the 
construct to be measured in the sample, both in terms of item relevance and 
item responsiveness.
2.4.4 Conclusion
The Barthel index and FIM are moderately responsive for patients 
undergoing neurological rehabilitation. The responsiveness of these 
measures is limited by poor item performance, which leads to an 
underestimation of the impact of rehabilitation. This study focused on 
clinician rated changes in physical and cognitive function; there was no 
measure of emotional wellbeing and no patient based outcome measure.
A more comprehensive view of the impact of rehabilitation can be achieved 
by using a wider range of outcome measures. Chapter 3 describes a study 
that examines the effectiveness of neurological rehabilitation in improving 
physical functioning and emotional wellbeing using patient based outcome 
measures.
95
Chapter 3 Measuring the Impact of Inpatient Rehabilitation
Chapter 3 Measuring the Impact of Inpatient Rehabilitation
3.1 Introduction
The last Chapter outlined the responsiveness of the Barthel index and FIM in 
a large sample of patients in inpatient neurological rehabilitation. While these 
measures underestimate the overall impact of rehabilitation on patients with 
neurological illness, they provide some evidence that neurological 
rehabilitation improves patients’ physical ability. But this is only one aspect of 
patients’ health related quality of life. Rehabilitation aims to improve a 
patient’s health status across a number of domains including physical ability, 
social functioning and emotional wellbeing. (Tulsky and Rosenthal 2002)
The effectiveness of rehabilitation in reducing physical impairments due to 
neurological illness has been established for patients with stroke. (Paolucci 
et al. 2000; Sim et al. 1997; Ronning and Guldvog 1998) These three studies 
demonstrated that patients made improvements in physical function with an 
inpatient multidisciplinary programme. Other studies have established the 
effectiveness of neurological rehabilitation in patients with spinal cord 
impairment, (Tow and Kong 1998; van der Putten et al. 2001) MS, (Freeman 
et al. 1997; Patti et al. 2003) traumatic brain injury, (Jorger et al. 2001; 
McPherson and Pentland 1997) and Guillain-Barre syndrome. (Nicholas et 
al. 2000; Meythaler et al. 1997)
Neurological rehabilitation has also been demonstrated to improve 
psychological wellbeing and health related quality of life after stroke,
(Hopman and Verner 2003) spinal cord impairment, (Tate etal. 2002) MS, 
(Wiles etal. 2001) and traumatic brain injury. (Johnston and Miklos 2002)
For neurological rehabilitation to be worthwhile, it is necessary for the gains 
made during rehabilitation to be maintained after discharge. The 
improvements in physical function and in psychological wellbeing made 
during inpatient neurological rehabilitation persist for a variable time after 
discharge. For instance, in stroke, the benefits on physical function persist 
for up to one year. (Suenkeler et al. 2002) Even in neurological illnesses 
known to deteriorate over time, such as progressive MS, improvements in 
physical function and emotional wellbeing can be maintained for between six 
and 10 months after discharge. (Freeman etal. 1999)
These studies have used a range of outcome measures, not all of which 
have been fully validated for use in neurological rehabilitation. Some 
outcome measures, such as the Barthel index, FIM and SF-36 have been 
shown to have satisfactory psychometric properties in a rehabilitation setting. 
However, the psychometric properties of other outcome measures, such as 
the 28-item General Health Questionnaire (GHQ-28), have not been 
evaluated in audits or studies of rehabilitation interventions. This is of 
particular importance with regard to responsiveness, which is a key property
of all outcome measures, particularly in the context of clinical trials. (Stucki et 
al. 1995a)
Outcome measures, particularly those measuring constructs such as 
emotional wellbeing, often employ a cutting score. (Allen and Yen 1979) A 
common example of this is the use of the GHQ-28 to indicate “caseness” in 
patients with emotional distress. That is, patients are considered to have a 
disruption of their emotional status, such that it warrants formal investigation 
by a psychiatrist, if they score above the cutting score. Cutting scores for 
outcome measures can be determined when patients can be categorised 
using a criterion, or gold standard test. The specificity and sensitivity for all 
possible scores on the outcome measure are calculated, and the score on 
the outcome measure that gives the optimum specificity and sensitivity when 
compared to the criterion is deemed to be the cutting score. This technique 
has been applied to the GHQ-28, for use as a screening instrument for 
emotional distress. Cutting scores were determined for different patient 
populations using structured psychiatric interviews, (Bridges and Goldberg 
1986) and the Hospital Anxiety and Depression Scale (HADS). (Feinstein et 
al. 1999) Using outcome measures as screening tests can be valuable in 
neurological rehabilitation where patients have to come to terms with newly 
acquired disabilities, and the consequent emotional distress may impede 
their recovery. (Mayo et al. 2002) It has been recommended that each unit 
that uses outcome measures in this way, determines the cutting score that 
best matches their individual population. (Bowling 2001)
The commonest symptoms of emotional distress in patients with neurological 
illness are anxiety and depression. (Feinstein etal. 1999) These symptoms 
contribute significantly to the morbidity of the original illness. Identifying these 
symptoms in patients can facilitate early treatment and an improved 
outcome. (Hassan et al. 2002)
This Chapter aims to explore the factors mentioned above, in a prospective, 
observational study. The study aims to examine the changes effected by 
neurological rehabilitation on patients’ physical function and emotional 
wellbeing using clinician rated and patient based outcome measures on 
discharge from rehabilitation and three months after discharge. The study will 
use the clinician rated Barthel index and FIM, and the patient rated self- 
report Barthel index, GHQ-28 and HADS. The study will also include an 
examination of the psychometric properties of these measures and a review 
of the most appropriate cutting score for the GHQ-28 in the NRU population.
3.2 Methods
This section describes the sample of patients recruited to the study, details 
the outcome measures used, and outlines the psychometric procedures used 
in this Chapter. The Joint Research Ethics Committee of the National 
Hospital for Neurology and Neurosurgery and the Institute of Neurology 
approved this study.
3.2.1 Sample
Recruitment of patients took place from 1st November 2002 to 31st May 2003. 
All patients that were admitted between these dates were invited to 
participate. Patients were asked to provide their written informed consent 
after reading the study information leaflet.
Demographic and diagnostic data were collected by patient interview and 
from the medical records within 48 hours of admission. Consenting patients 
were asked to complete a questionnaire booklet containing self-report 
outcome measures. Antidepressant use was recorded for each patient during 
his or her admission. Within the 72 hours prior to discharge, patients were 
again asked to complete a questionnaire booklet. Discharge destination was 
recorded and contact details for follow-up information were confirmed with 
each patient.
Three months from the discharge date, a questionnaire booklet was sent to 
each patient with a request to complete and return it  These questionnaires 
were developed using the total design method as described by Dillman. 
(Dillman 1978) An initial letter reminding each patient of the study was sent 
first. This was followed seven days later by a letter explaining the study, the 
questionnaire booklet and a stamped addressed envelope. A reminder letter 
was sent if the booklet was not returned after 10 days. If not returned by 
three weeks, a further questionnaire booklet and stamped addressed 
envelope was sent to the patient’s address.
3.2.2 Outcome Measures
Five outcome measures were used in this study. The Barthel index and FIM 
as outlined in the previous Chapter were scored by the treating 
multidisciplinary team on admission and discharge. Patients were asked to 
complete the self-report Barthel index, the GHQ-28 and the Hospital Anxiety 
and Depression Scale (HADS) on admission, discharge and follow-up. In 
addition to the outcome measures on discharge, a transition question with 
respect to change in mood was asked. For this question, patients were 
asked to rate how their mood had changed since admission. The response to 
this question was graded with a Likert scale with the following response 
options: much worse, worse, the same, better, much better. (Likert 1932)
The outcome measures were chosen to reflect the potential changes in 
physical function and emotional wellbeing, particularly anxiety and 
depression, which would be expected in patients in neurological 
rehabilitation. The Barthel index, FIM and GHQ-28 were already in routine 
use in the NRU. The self-report Barthel index was used to measure physical 
function after discharge. The HADS was chosen as it has been shown to be 
sensitive and specific in detecting post-stroke depression and emotional 
disturbance in people with MS. (Feinstein et al. 1999; Johnson et al. 1995) 
This would allow the HADS to be used to determine the optimal cutting score 
of the GHQ-28.
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The self-report Barthel index, the GHQ-28 and the HADS are described in 
the following paragraphs with a summary of their psychometric properties.
Self-report Barthel index: This was developed from Collin’s 1988 version of 
the Barthel index. (Collin etal. 1988) It was designed as a self-report 
outcome measure for use in postal surveys. (Gompertz et al. 1994) The 10 
items of the clinician scored Barthel index were converted into multiple 
choice questions and scored according to the published guidelines 
(Appendix 1). As with the clinician scored Barthel index, the items are 
summated to give a total score from 0 to 20, with higher scores indicating 
greater independence in activities of daily living.
The self-report Barthel index has good acceptability and test-retest reliability 
in patients with stroke living in the community. (Gompertz et al. 1994) High 
interrater reliability has been demonstrated between scores obtained by 
patient self-report and clinician scoring. (Hobart et al. 1996b)
GHQ-28: This is a 28-item self-report questionnaire of emotional wellbeing 
first published in 1979. (Goldberg and Hillier 1979) It has four sub-categories 
measuring somatic symptoms, insomnia and anxiety, social dysfunction, and 
severe depression, each of which can be analysed separately (Appendix 2). 
Initially developed in general practice, it has been used in studies of patients 
with MS, (Feinstein etal. 1999) stroke (Johnson etal. 1995) and in general 
neurological inpatients. (Lykouras etal. 1996) In the original publication, the
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authors recommended scoring each item dichotomously and summating the 
items to give a total score from 0 to 28. (Goldberg and Hillier 1979) Lower 
scores indicate better emotional wellbeing. A cutting score of five or more 
indicates emotional disturbance in general practice patients. When this 
cutting score is applied in patients with a range of neurological illnesses, 
including MS, stroke and Parkinson’s disease, prevalence rates of emotional 
disturbance exceed 50% of the sample. (Bridges and Goldberg 1986; Rabins 
and Brooks 1981) Consequently, other authors have recommended using 
cutting scores of six (Lykouras et al. 1996) or 12 which improve the 
sensitivity and specificity of the GHQ-28 in detecting emotional disturbance. 
(Bridges and Goldberg 1986)
The GHQ-28 was developed from the 60-item General Health Questionnaire. 
Internal consistency of the GHQ-28 is reported to be high. (Failde et al.
2000) Test-retest reliability has not been reported in the literature. Using the 
60-item version as a reference, the shorter version demonstrated good 
criterion validity. (Goldberg and Hillier 1979) It has also been demonstrated 
to have construct validity when tested against clinical psychiatric 
examination. (Rabins and Brooks 1981) One potential problem with the 
GHQ-28 is that the first seven items are related to physical symptoms of 
emotional disturbance, for example, poor energy levels, headache and hot or 
cold spells. It has been reported that this may result in a high false-positive 
rate when the GHQ-28 is used in patients with neurological illness, as these 
symptoms are commonly seen in neurological conditions, so will be 
endorsed by patients when the symptoms are due to a physical, not a
psychological cause. (Bowling 2001) For this reason, some authors find the 
HADS preferable, as it does not contain items relating to physical symptoms.
HADS: Published in 1982, the HADS has 14-items, seven of which measure 
anxiety and seven that measure depression. (Zigmond and Snaith 1983) It 
was developed to provide a short outcome measure that could identify these 
two constructs in patients with physical illness (Appendix 3). The authors felt 
that the General Health Questionnaire was too long and did not give specific 
information about the nature of the emotional disorder. They felt that the 
scale should be limited to anxiety and depression, as these are the most 
common emotional disorders seen in patients in hospitals. Furthermore, 
items relating to physical manifestations of emotional disorders were 
specifically avoided to reduce the chance of false-positive results.
Each of the items in the HADS is scored from 0 to 3. The anxiety and 
depression scales are summated separately giving scores ranging from 0 to 
21 for each construct. Lower scores indicate less anxiety and depression 
respectively. Scores of seven or less are normal, those between eight and 10 
are borderline, and scores of 11 or more are abnormal. The HADS has been 
used widely in hospital and general practice settings. It has been used for 
screening for anxiety and depression in patients with stroke (Johnson et al. 
1995) and MS. (Feinstein etal. 1999)
The HADS has been demonstrated to be internally consistent (Mykletun et 
al. 2001) and have test-retest reliability. (Gold etal. 2003) Construct validity 
has been established against other measures of anxiety and depression. 
(Bjelland et al. 2002)
3.2.3 Analyses
This section describes the procedures carried out to compare the patients’ 
scores on admission, discharge and follow-up to determine the effect and 
durability of the rehabilitation process. It also describes the techniques used 
to establish the psychometric properties of the outcome measures to ensure 
that they are appropriate for use in this population and how the cutting score 
for the GHQ-28 was determined. Analyses were performed with SPSS 
Version 11. (SPSS Incorporated 2002)
Descriptive statistics: The mean and standard deviation or frequency were 
calculated for demographic variables, outcome measure scores and 
transition questions. Paired t-tests were used to compare scores from 
admission to discharge and discharge to follow-up. Independent f-tests were 
performed to examine whether the following characteristics affected patients’ 
rehabilitation outcome: age greater than the median, sex, presence of 
anxiety or depression, antidepressant use, and onset of neurological 
disability (acute or chronic).
Acceptability: Acceptability of the self-report Barthel index, GHQ-28 and 
HADS was determined by calculating percentage of missing items for each 
measure. Failure to answer items can be due to the items being irrelevant, 
inappropriate or intrusive. (Lohr et al. 1996) This study used a transition 
question asking each patient how easy he or she found the questionnaires to 
answer. (Andresen et al. 1998) The response options were: very difficult, 
difficult, easy and very easy.
Acceptability of the measures was also evaluated by examining mean 
scores, standard deviations and score ranges. Floor and ceiling effects were 
calculated for the self-report Barthel index, GHQ-28 and the anxiety and 
depression scales of the HADS.
Reliability: Reliability was estimated by using Cronbach’s alpha (Cronbach 
1951) and item-total correlations. Cronbach’s alpha should be greater than 
0.70. (Fitzpatrick et al. 1998) The item-total correlation examines the 
correlation between each item and the measure with the item removed.
Items should correlate with the measure at r>  0.20. (Streiner and Norman 
1995)
Validity: In this study it was postulated that the self-report Barthel index 
would correlate strongly with the clinician scored Barthel index and FIM, and 
the GHQ-28 would demonstrate convergent validity with the depression 
scale of the HADS. Discriminant validity was expected between the GHQ-28
and HADS, and the self-report Barthel index. Construct validity would, 
therefore, provide evidence for the use of these instruments in measuring the 
two constructs of physical function and emotional wellbeing.
Acceptability, reliability and validity statistics for the outcome measures were 
calculated on the patients’ scores on admission, as the greatest number of 
patients completed the admission outcome measures.
Responsiveness: For the GHQ-28 and HADS, effect sizes were calculated 
for the sample as a whole and for patients in each response category of the 
transition question. (Middel et al. 2001) This technique allows external 
validation of the effect size statistic by comparing it to the patient’s own 
opinion of the change in their emotional wellbeing. In this way, clinical 
change as perceived by the patient is placed in the context of the answers 
given to the items of the GHQ-28 and HADS at the end of his or her NRU 
admission.
ROC analysis: Receiver operating characteristic (ROC) analysis is a graphic 
representation of the relationship between the sensitivity and the specificity 
of an instrument. ROC analysis determines the best cutting score that 
maximises the true-positive rate (sensitivity) whilst minimising the false- 
positive rate (1-specificity). ROC analysis has been used to determine cutting 
scores for the GHQ-28 in previous studies and is recommended by the 
developers of the instrument. (Lykouras etal. 1996) An ideal instrument, with
perfect sensitivity and specificity, would be represented by the top left-hand 
point of the graph. When the data are plotted on the graph for all possible 
scores of the GHQ-28, the point on the curve closest to the top left-hand 
point represents the cutting score with the best combination of sensitivity and 
specificity. The HADS depression scale was used as the reference in the 
ROC analysis.
These procedures were used to examine the response of patients to 
neurological rehabilitation, to establish the properties of these outcome 
measures in this population, and to determine the optimum cutting score for 
the GHQ-28.
3.3 Results
The results of the analyses performed on the data gathered are presented in 
this section. The demographics of the sample are presented initially, followed 
by the results from the measures of physical function (Barthel index, FIM, 
self-report Barthel index), then the measures of emotional well being (GHQ- 
28, HADS) and finally, the psychometric analyses.
3.3.1 Demographics
Over the course of the recruitment period, 70 patients were admitted to the 
NRU for inpatient rehabilitation. A flow diagram illustrating the recruitment of 
patients to the study is presented in Figure 3.1. Three patients declined to
take part, but did not give reasons why. Four patients were unable to 
complete the questionnaires: two patients were unable to speak English and 
two patients were unable to communicate due to profound aphasia.
Figure 3.1 Recruitment to the study
70 patients admitted 
\
^  3 declined to participate; 4 unable to complete questionnaire
63 consented to take part and completed admission questionnaire 
\
2 transferred off NRU; 1 did not complete discharge questionnaire 
60 completed discharge questionnaire
N 2 patients RIP; 2 change of residence after discharge; 4 no reply 
52 returned completed follow-up questionnaire
Over the course of the study, two patients became unwell and were 
transferred off the NRU for medical treatment. These patients did not 
complete their rehabilitation and were not followed-up. One patient did not 
complete the discharge questionnaires.
Of the 60 patients who completed discharge questionnaires, 52 patients 
returned a completed questionnaire booklet three months after discharge. Of 
the eight who did not, two patients died in the intervening period, both from 
pneumonia. Two patients had been homeless on admission, and letters to 
the addresses that they were allocated on discharge were returned
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unopened. Four patients did not reply to the mailings. The response rate is 
calculated from the number of those who returned the questionnaire (52) 
divided by the number (56) who could have completed the questionnaire 
(that is, those known to be living at a valid address) and, for this study, it is 
93%. There were no systematic differences in admission and discharge 
scores between those who returned the questionnaire booklet and those who 
did not.
The demographics of the 63 patients who consented to take part and who 
completed the admission questionnaires are described in Table 3.1. There 
were more males than females in the sample. The median age of patients 
was 45 years. Apart from patients with spinal cord injuries, stroke and MS, 
there was a range of other neurological illnesses represented in the sample. 
The mean age, and age range, of the patients in this study are similar to 
those seen in the NRU over the last 10 years, as described in the last 
Chapter.
Table 3.1 Patients’ demographics on admission
Variable
Sex
Male n (%) 34 (55%)
Female n (%) 29 (45%)
Age Mean (SD; range) 48 (16; 2 0 -8 8 )
Diagnosis n (%)
Spinal cord lesion 17 (26%)
Stroke 16 (25%)
MS 12(19%)
GBS 6(10%)
Cerebral tumour 3 (5%)
Acquired brain injury 2 (3%)
Cerebral palsy 2 (3%)
Movement disorder 2 (3%)
Miscellaneous 3 (5%)
Admitted from
NHNN 28 (44%)
Home 25 (40%)
Other hospitals 9 (14%)
Other rehabilitation units 1 (2%)
Patients’ lengths of stay in rehabilitation were also similar to lengths of stay 
of patients with similar diagnoses in other years. The mean length of stay for 
all patients was 38 days, with a standard deviation of 26 days, and ranged 
from 16 to 168 days. Of the 60 patients who completed the discharge 
questionnaires, 59 patients were discharged home from the NRU. Two 
patients chose to be discharged to nursing homes, one patient with cerebral 
palsy returned to the sheltered accommodation he had been living in prior to 
his illness and the two patients who were homeless on admission were 
discharged to the homeless persons unit. One patient was discharged to 
continue his rehabilitation in another rehabilitation unit.
3.3.2 Physical Function
Over the course of the study there was a statistically significant improvement 
(p < 0.001) in all measures of physical function. Table 3.2 outlines the 
changes between admission and discharge on the Barthel index, FIM and 
self-report Barthel index. This table includes the effect size for each of the 
measures.
Effect sizes were moderate to large (0.68 to 0.82) for each of the outcome 
measures of physical function indicating good improvement. The FIM 
cognitive scale effect size was 0.25, which is in the same range as the 
results for this measure in the previous Chapter.
At three months physical function remained at discharge levels for the self- 
report Barthel index with a mean value of 15.8, standard deviation 4.2. This 
represents a fall in this measure of 0.8, which is not significant.
Table 3.2 Physical function measures: admission and discharge
Outcome measure Admission 
score (SD)
Discharge 
score (SD)
Mean
change
Significance Effect
size
FIM total 89.6 (22.5) 108.1 (16.9) 17.9 p < 0.001 0.82
FIM motor 59.6 (21.1) 76.8 (14.3) 16.6 p < 0.001 0.81
FIM cognitive 29.7 (5.6) 31.1 (4.9) 1.5 p < 0.001 0.25
Barthel index 12.7 (5.8) 17.3 (3.5) 4.5 p < 0.001 0.79
Self-report Barthel 13.2 (4.9) 16.5 (3.6) 3.3 p < 0.001 0.68
Self-report Barthel index: The self-report Barthel index demonstrated good 
acceptability, internal consistency and construct validity against the clinician 
scored Barthel index and FIM (Table 3.3). The item-total correlations were 
greater than 0.30 for all items except the bladder item. Apart from this result, 
the self-report Barthel index met or exceeded the psychometric criteria as 
described in the methods section.
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Table 3.3 Psychometric properties of the self-report Barthel index
Property
Acceptability
Missing items % 0%-8%
Floor/ceiling effects % 0% / 9.5%
Scale range 0 - 2 0
Score range 2 - 2 0
Mean score (SD) 12.9 (5.1)
Reliability
Item-total correlations 0.17-0.81
Cronbach’s alpha 0.83
Validity (Pearson’s correlation)
Barthel index 0.77
FIM motor 0.77
FIM total 0.75
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3.3.3 Emotional Wellbeing
In a similar pattern to the physical changes, emotional wellbeing improved 
from admission to discharge. The GHQ-28 and HADS depression scale 
demonstrated a statistically significant decrease (p < 0.001). The HADS 
anxiety scale did not show a significant decrease (p = 0.050). Admission and 
discharge scores with effect sizes are presented in Table 3.4. There was a 
large improvement (0.91) in emotional wellbeing as measured by the GHQ- 
28. The change for the HADS depression scale was small to moderate (0.43) 
and small for the HADS anxiety scale (0.22).
Table 3.4 Emotional wellbeing measures: admission and discharge
Outcome Admission Discharge Mean Significance Effect
measure score (SD) score (SD) change size
GHQ-28 8.3 (6.2) 2.7 (3.5) 6.2 p < 0.001 0.91
HADS
Depression 6.3 (4.8) 4.2 (3.5) 2.1 p < 0.001 0.43
Anxiety 5.7 (4.3) 4.8 (4.4) 0.9 p = 0.050 0.22
By follow-up at three months, the mean GHQ-28, HADS depression and 
anxiety scores were 6.6, 6.5 and 6.6 respectively (Table 3.5). These scores 
did not differ significantly from the corresponding scores on admission. 
However, all three had increased significantly on the corresponding 
discharge scores (p < 0.002).
Table 3.5 Emotional wellbeing measures: follow-up
Outcome Follow-up Mean change Discharge to 
measure score (SD) discharge to follow-up
follow-up significance
GHQ-28 6.6 (6.9) -4.1 p < 0.001
HADS
Depression 6.5 (4.4) -2.2 p < 0.001
Anxiety 6.6 (5.1) -1.39 p =0.002
HADS scores: Admission and discharge HADS scores were categorised 
into groups according to the classification as outlined in the methods section. 
On admission, four patients had abnormal levels of anxiety alone, four had 
abnormal levels of depression alone, and five patients had abnormal levels 
of both (Table 3.6). Results are included for the 60 patients who completed 
both admission and discharge HADS questionnaires and the 52 patients who 
completed the follow-up questionnaire. As expected from the total score 
changes in the HADS scales, there was a decrease in the number of patients 
in the borderline and abnormal categories for the depression scale from 
admission to discharge. But for the anxiety scale there was only a decrease 
of two in the number of borderline cases and one in the number of abnormal 
cases. The follow-up anxiety and depression categories indicate increases in 
the numbers of patients with borderline or abnormal states in a similar 
pattern to the total scores for those scales.
Table 3.6 HADS categories: admission, discharge and follow-up
HADS Category 
Normal Borderline Abnormal
Anxiety
Admission 45 6 9
Discharge 48 4 8
Follow-up* 31 11 10
Depression
Admission 37 14 9
Discharge 52 5 3
Follow-up 31 13 8
Subgroup analysis: Change in patients’ scores was not affected by age, 
sex, anxiety, depression or antidepressant use. The only variable of 
significance was whether patients had acute onset of illness or had a chronic 
disability prior to this admission for rehabilitation. This difference was only 
significant for the GHQ-28 score at discharge, which demonstrated a greater 
improvement in emotional wellbeing for patients with chronic disability, than 
for patients with acute onset of illness (Table 3.7).
* Only 52 patients completed the follow-up HADS questionnaires
Table 3.7 Emotional wellbeing measures: acute onset versus chronic
Outcome
measure
Admission to discharge
Admission Discharge Significance 
score score
Effect
size
Discharge to follow-up
Follow-up Significance 
score
GHQ-28
Acute 7.8 3.8 p < 0.001 0.82 6.3 p = 0.011
Chronic 8.4 1.7* p < 0.001 0.91 6.1 p = 0.026
HADS
Depression
Acute 6.5 4.1 p = 0.002 0.47 6.9 p < 0.001
Chronic 6.2 4.5 p = 0.042 0.32 6.1 p = 0.025
Anxiety
Acute 5.4 4.5 p = 0.160 0.26 7.1 p = 0.014
Chronic 6.6 5.0 p = 0.155 0.18 6.1 p = 0.073
* Difference between patients with acute and chronic illness significant at p = 0.45, all other 
differences not significant
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3.3.4 Psychometric Analysis
Acceptability: The GHQ-28 and HADS demonstrated good acceptability 
(Table 3.8). There were very few missing items in the HADS scales, with a 
slightly higher percentage in the GHQ-28. Those items with the greatest 
number of missing items were primarily in the severe depression subscale, 
which includes questions about suicide. Fifty-eight patients reported that they 
found the questionnaires easy or very easy to answer. Three patients found 
the questionnaires difficult; two patients did not endorse any category in this 
question. Floor and ceiling effects were minimal, apart from the floor effect of 
the GHQ-28, which was 28%.
Reliability: The internal consistency of the GHQ-28 and HADS scales were 
within the criteria as outlined in the methods section. Only one item of the 
GHQ-28 (having hot or cold spells) had an item-total correlation less than 
0.20; all other items were greater than 0.20.
Validity: Construct validity was demonstrated by moderate correlations 
between the anxiety and depression scales of the HADS and moderate 
correlations between the GHQ-28 and the HADS scales (Table 3.8). There 
were low correlations between the measures of emotional wellbeing and the 
self-report Barthel index as expected. Correlations between emotional 
wellbeing and age and sex of patients were less than r -  0.20.
Table 3.8 Psychometric properties of the GHQ-28 and HADS
Measure GHQ-28 HADS
Depression Anxiety
Acceptability
Missing items % 0%-10% 0%-2% 0%-1%
Floor/ceiling effects % 28% / 2% 6%/2% 8% / 0%
Scale range 0 - 2 8 0-21 0 - 2 1
Score range 0 - 2 8 0- 21 0 - 1 8
Mean score (SD) 6.2 (7.3) 6.4 (4.8) 5.9 (4.4)
Reliability
Item-total correlation 0.18-0.82 0.38 -  0.67 0.53 -  0.80
Cronbach’s alpha 0.95 0.82 0.86
Validity (Pearson’s correlation)
GHQ-28 0.674 0.647
HADS Depression 0.662
Self-report Barthel -0.04 -0.12 -0.14
When the GHQ-28 insomnia and anxiety subscale was examined against the 
HADS anxiety scale, there was a correlation of r = 0.717. This indicates that 
these two scales measure the same construct. The other three subscales of 
the GHQ-28, somatic symptoms, social dysfunction and severe depression 
correlated at lower levels with the HADS anxiety and depression scales 
(Table 3.9).
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Table 3.9 Correlations between GHQ-28 and HADS subscales
HADS
Depression Anxiety
GHQ-28 Subscale
Somatic symptoms 0.498 0.496
Anxiety 0.640 0.717
Social dysfunction 0.663 0.541
Severe depression 0.503 0.604
Responsiveness: Table 3.10 presents the effect sizes for the patients 
stratified by the response they gave to the transition question regarding 
mood on discharge. No patients endorsed the worse or much worse 
categories in the transition question. For the GHQ-28 and HADS depression 
scale there was concordance between the transition question categories and 
the effect size for the scales.
Table 3.10 Discharge transition question
Effect size
Transition Number of GHQ-28 HADS HADS
question patients Depression Anxiety
Much better 22 1.25 0.75 0.20
Better 23 0.69 0.28 0.19
The same 15 0.66 0.12 0.27
Worse 0
Much worse 0
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Cutting score: Using the standard cutting score of five or more, 41 (65%) 
patients were classified as having emotional disturbance on admission. 
When the GHQ-28 results were plotted on the ROC curve, the optimum 
cutting point for this sample was established as six (Figure 3.2). That is, a 
score of six or more on the GHQ-28 indicates emotional disturbance. Using 
this new cutting score reduces the number of patients with emotional 
disturbance to 36 (57%). The sensitivity and specificity for this cutting score 
were 75.0% and 79.3% respectively.
Figure 3.2 ROC curve for GHQ-28
Arrow indicates point of greatest sensitivity and 1-specificity
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3.4 Discussion
3.4.1 Summary of Results
This observational study has three main findings. Firstly, emotional distress 
is very common amongst patients with neurological conditions. Neurological 
rehabilitation improves emotional wellbeing, but the effect is not enduring. 
Secondly, the outcome measures used in this study are psychometrically 
sound, and in particular are responsive when used to detect change in 
neurological rehabilitation. Thirdly, a higher cutting score for the GHQ-28 is 
required for patients with neurological conditions than that recommended for 
general populations.
This study describes high levels of anxiety and depression in patients on 
admission to a neurological rehabilitation unit. The level of depression is 
comparable to that seen in other studies of depression in neurological illness. 
(Sadovnick et al. 1996; Turner-Stokes and Hassan 2002; Kennedy and 
Rogers 2000) What this study adds, however, is that while physical function 
and depression improve in patients undergoing rehabilitation, anxiety 
remains elevated. Anxiety has been identified as an important contributor to 
poor quality of life in patients with chronic neurological illnesses. (Feinstein et 
al. 1999) In Feinstein’s study, anxiety, accompanied by depression, in 
patients with MS, was associated with more frequent thoughts of self-harm 
and greater social dysfunction. It is being increasingly recognised that 
combined anxiety and depression is the most common affective disorder in 
general psychiatric practice. (Shorter and Tyrer 2003) This study provides
evidence that this may also be the case amongst patients in rehabilitation, as 
five patients had combined anxiety and depression, which was more than 
had depression alone (four).
However, the impact of anxiety or depression on physical function is not 
certain. Some studies have suggested that physical function after stroke is 
impaired by depression, (Johnson et al. 1995) whereas others have not 
found any relationship. (Cassidy et al. 2004) This study found no association 
between anxiety, depression and physical function, though the numbers in 
these analyses are small.
The patient based outcome measures used in this study, the self-report 
Barthel index, the GHQ-28 and HADS, are responsive to changes brought 
about by neurological rehabilitation in this sample. The responsiveness of the 
GHQ-28 and HADS, as measured by the effect size statistic, was in keeping 
with the direction and magnitude of change indicated by the patients’ opinion 
of the change in their emotional wellbeing. The GHQ-28 is more responsive 
(effect size 0.91) than the HADS depression scale (effect size 0.43) in 
detecting change in emotional wellbeing. This may be due to the GHQ-28 
sampling a wider construct of emotional wellbeing from social dysfunction to 
severe depression and so detecting change in a range of areas that 
rehabilitation aims to improve. The changes in these individual areas will 
then contribute to overall responsiveness.
These results demonstrate that the self-report Barthel index, GHQ-28 and 
HADS are acceptable, reliable and valid in patients undergoing inpatient 
rehabilitation. They are also suitable for assessing the status of patients after 
they have been discharged from rehabilitation. The three measures have 
good acceptability in patients recently admitted for rehabilitation. Internal 
consistency is high as measured by standard indices. There is construct 
validity between the self-report Barthel index and the clinician scored Barthel 
index and FIM indicating that the self-report Barthel index can be used to 
measure physical function in this sample after discharge. Total and subscale 
scores of the GHQ-28 and the HADS scales correlate in the moderate to 
high range, indicating that they measure related but distinct constructs. Both 
scales measure anxiety and depression, and the GHQ-28 also measures the 
related constructs of somatic symptoms and social dysfunction.
Findings in this study are consistent with previous studies that have 
evaluated the measurement properties of the self-report Barthel index, the 
GHQ-28 and the HADS. The self-report Barthel index has been shown to be 
acceptable and reliable in patients with stroke. (Gompertz et al. 1993; 
Gompertz et al. 1994) Construct validity has been demonstrated previously 
with the clinician scored Barthel index. (Hobart et al. 1996b) There are no 
studies that have used the self-report Barthel index during inpatient 
rehabilitation and then after discharge to assess physical function.
This is the first study to examine the acceptability and internal consistency of 
the GHQ-28 in patients with neurological illness in rehabilitation. Internal 
consistency in this setting was similar to that seen when the measure has 
been used in other medical illnesses. (Failde et al. 2000) Construct validity of 
the GHQ-28 has previously been shown with other measures of emotional 
wellbeing such as the Schedule of Recent Experience (Rabins etal. 1986) 
and structured interviews. (Bridges and Goldberg 1986; Lykouras et al. 1996)
The acceptability and reliability of the HADS has not been tested before in 
patients in neurological rehabilitation. Findings in this study for internal 
consistency and validity of the HADS are, however, comparable with a 
previous study involving patients with neurological illness. (Gold et al. 2003)
The cutting score for the GHQ-28 of six or more found by this study to give 
optimum sensitivity and specificity to detect emotional disturbance, is the 
same as that found by other studies of patients with neurological illness. 
Johnson’s study, of patients with post-stroke depression, reported that a 
cutting score of six or more resulted in a sensitivity of 78% and specificity of 
81% in detecting emotional disturbance. (Johnson etal. 1995) Lykouras’ 
study of general neurological inpatients, using the same cutting score, 
reported a sensitivity of 87% and specificity of 77%. (Lykouras etal. 1996) 
This study found lower sensitivity, but equal levels of specificity.
Applying the new cutting score of six or more to the sample in this study 
reduced the number of patients classified as having emotional disturbance 
by 8% to 57%, compared to the original cutting score of five or more. This is 
similar to the level of emotional disturbance seen in other studies involving 
patients with neurological illness. Rabins, in two studies of outpatients with 
MS, reports that between 47% and 52% of patients have emotional 
disturbance using the GHQ-28 with a cutting score of five or more. (Rabins 
and Brooks 1981; Rabins et al. 1986) These studies included a wide range of 
patients with MS, from newly diagnosed to those with physical and cognitive 
impairments. Fifty-six of 107 (52%) patients in Lykouras’ study had emotional 
disturbance. (Lykouras et al. 1996) Patients in that study also ranged from 
newly diagnosed to chronically unwell, and had a wide range of diagnoses, 
with demyelinating diseases (17%), myopathy (14%) and epilepsy (13%) 
being the three most common diagnoses.
There are differences between the results of this study and a previous study 
performed in the NRU. Freeman et al reported enduring improvements in 
emotional wellbeing in patients with progressive MS following inpatient 
rehabilitation. (Freeman et al. 1999) Median GHQ-28 scores decreased from 
9.5 on admission to 1.5 on discharge and remained below five for up to one 
year. However, there are a number of important differences between the two 
studies. All patients in Freeman’s study had MS with a mean duration of 
illness of 15.3 years. But in this study, only 12 (19%) patients had MS, and 
38 (60%) patients were admitted with an acute onset of neurological illness. 
Furthermore, patients in this study were followed-up with a postal
questionnaire at three months, but in Freeman’s study, patients were seen 
every three months for a year. These variations between patient populations 
and methodology are most likely to be responsible for the differences 
between the two studies.
In summary, neurological rehabilitation produces improvements in physical 
functioning that persist for at least three months, and improvements in 
emotional wellbeing, which deteriorate after discharge. The self-report 
Barthel index, GHQ-28 and HADS are psychometrically sound outcome 
measures in neurological rehabilitation.
3.4.2 Study Strengths and Limitations
This study included all patients admitted to a neurological rehabilitation unit 
over a seven-month period who consented and who were able to 
communicate with an interviewer. The results of this study refer to a sample 
of patients with a casemix of acute and chronic neuromedical and 
neurosurgical illnesses. There was a wide age range, and male and female 
patients were equally represented. Patients were admitted from home and 
from hospitals in the Greater London area.
Scores on admission for the measures of physical function and emotional 
wellbeing spanned the range of the measurement scales. The patients 
reported in this study have similar levels of disability to those reported in 
other studies. (Post et al. 2002; Sim et al. 1997; Tennant et al. 1996; Tow
and Kong 1998; van Bennekom et al. 1996; Ronning and Guldvog 1998) 
Other studies have described patients with higher, (Hsueh et al. 2002; 
Paolucci et al. 2000; Patel et al. 1998; Scivoletto et al. 2003) and with lower 
levels of disability. (Craig et al. 2003; Salbach et al. 2001; Wallace et al.
2002) Levels of emotional disturbance were similar to those seen in patients 
hospitalised with neurological illness. (Lykouras et al. 1996; Rabins and 
Brooks 1981; Rabins et al. 1986) The characteristics of this sample, with 
respect to demographics and scores on outcome measures, suggest that it is 
representative of other groups of patients in neurological rehabilitation.
A further strength of this study is the consistency of input from the 
rehabilitation team. Patients were treated by a multidisciplinary team 
experienced in treating patients with neurological illnesses. Outcome 
measurement is an integral part of the rehabilitation process in the NRU and 
rehabilitation outcomes are audited three-monthly. The results of this study 
are consistent with the outcomes in the NRU for the year prior to the start of 
the study and the three months since the study finished. The study did not 
affect the team’s scoring of the clinician scored outcome measures or the 
rehabilitation interventions the patients received. These factors support the 
generalisability of these results to other patients who may be admitted to the 
NRU.
Ideally, this study would have incorporated a control group. However 
logistical considerations meant that it was not possible to conduct a
randomised double blind trial without huge resource implications. Ethical 
concerns would not allow delay in treating patients with acute conditions 
where there is strong evidence that rehabilitation is effective and prevents 
secondary complications, for example, in stroke and in spinal cord injury 
rehabilitation. (Edwards et al. 2002; Inman 1999)
This study excluded patients who were unable to communicate sufficiently to 
provide answers to the self-report questionnaires. Every effort was made to 
ensure as many patients as possible were invited to participate, but patients 
with profound aphasia or insufficient skill in English could not be included. 
The exclusion of these patients means that patients with the most severe 
participation restrictions were not included. This limits the generalisability of 
the results to these patients. One method of including patients with severe 
communication impairment is to ask a family member or carer to act as a 
proxy. This technique has been used in assessing outcome in traumatic 
brain injury and stroke rehabilitation and may warrant further investigation as 
a method of obtaining outcome measurement data from these patient 
groups. (Cusick et al. 2000; Sneeuw et al. 1997)
A potential limitation to the follow-up arm of the study is non-respondent bias 
from those who did not return the questionnaires. While a well-established 
method was chosen to facilitate as high a response rate as possible, non­
response was an unavoidable consequence of postal questionnaire follow- 
up. It is not possible to determine how the results of the study might have
differed if they had included those who did not reply, however, there were no 
systematic differences between those who did and those did not respond to 
the postal questionnaire.
3.4.3 Implications for Clinical Practice
The results of this study have several implications for clinical practice. First, it 
is important to measure a range of constructs when evaluating patients’ 
progress, both during and after a rehabilitation programme, to 
comprehensively evaluate their outcome. Second, emotional wellbeing 
deteriorates after discharge, therefore it is important to develop strategies to 
identify and assist those patients who have emotional disturbance. Third, it is 
possible to measure accurately the impact of rehabilitation in patients while 
they are in a rehabilitation unit and after discharge using self-report 
questionnaires, and these could be used more extensively by rehabilitation 
teams.
Rehabilitation is a complex process that can effect improvements in physical 
function and emotional wellbeing in patients with neurological conditions. The 
goal of a rehabilitation intervention may be to reduce a patient’s impairment, 
improve an activity or enhance his or her participation. Health related quality 
of life is the interaction of a patient’s impairments, activities and level of 
participation, with his or her social and personal background. (Carr etal.
2001) But health related quality of life is difficult to determine 
comprehensively. (Ware, Jr. 2003; Testa and Simonson 1996) The practical
consequence of this is that most studies of rehabilitation aim to assess only a 
representative portion of the constructs that potentially could be measured. 
Physical function and emotional wellbeing are the two most commonly 
measured constructs in studies of rehabilitation interventions, particularly in 
patients with neurological illnesses.
It is important that rehabilitation programmes routinely measure as wide a 
range of constructs as possible for two reasons. Firstly, biometric data, such 
as blood pressure, or laboratory or radiological results are generally of 
limited interest to patients, but more importantly, often correlate poorly with 
function and wellbeing. (Guyatt et al. 1993) Secondly, patients with the same 
impairments rarely have the same limitations in activity or participation. 
Although some patients may continue to work and participate in leisure 
activities, others may become unemployed and restrict their lifestyles. 
(Larocca et al. 1985) By using a range of patient based outcome measures it 
will be possible to develop a clear appreciation of the patients’ current 
functional status and their understanding of their own abilities.
Measuring physical function -  walking, activities of daily living, upper limb 
tasks -  is a core element of neurological rehabilitation programmes. (Wade 
1993) However, most measurement of physical function is clinician scored. 
There is increasing interest in patient based outcome measures, not just of 
constructs such as psychological or social functioning, but also of physical 
function. (Hobart 2002) The self-report Barthel index is one such measure.
More recent work emphasises developing measures using psychometric 
principles; an example of which is a scale to measure the patient’s 
perspective of the impact of MS on his or her walking ability. (Hobart et al.
2003) The MS Walking scale is an outcome measure, developed using 
psychometric methods, that contains 12 items, which are based on 
statements made by patients with MS about their walking ability. Therefore, it 
provides scientific data of the patients’ opinions by asking questions that 
patients themselves have identified as important.
There is evidence that patients’ opinions are significantly different to those of 
clinicians’ in a range of situations. (Wilson and Cleary 1995) Taking the 
patients’ opinions into account can facilitate decision making when those 
wishes are clearly known. Furthermore, if patients feel that clinicians are 
interested in their opinions and are taking them into account when treating 
them, then the patients are more likely to comply with treatment. (Jones 
2003; Javors and Bramble 2003) This is an important issue when patients 
with chronic neurological illnesses are discharged from rehabilitation with 
home management programmes to prevent secondary complications such 
as muscle contractures and pressure sores. Using patient based outcome 
measures in these situations to allow clinicians to comprehend the patients’ 
understanding of their situation may improve compliance with treatment.
Several studies have demonstrated that compliance with treatment may also 
be affected by emotional disturbance. (Sinyor et al. 1986; van de Weg et al.
1999) As discussed earlier in this Chapter, rehabilitation for neurological 
illnesses can improve emotional wellbeing. However, deterioration in 
emotional wellbeing occurs after discharge from rehabilitation. Why this 
occurs has not been adequately explained, and emotional wellbeing can 
deteriorate despite stable or improving physical function. (Suenkeler et al.
2002) Hopman has suggested that restricted social role after discharge may 
influence wellbeing. (Hopman and Verner 2003) Patients returning to their 
home environment following a neurological illness will be reminded of their 
functional limitations and loss of independence. Patients will also be unable 
to return to other activities such as driving or work, which may have formed a 
part of their normal social role before the onset of neurological illness. 
Detecting and treating emotional disturbance may play a role in improving 
the outcome of rehabilitation programmes. But to treat emotional disorders, 
they must first be detected. This can readily be achieved in a neurological 
rehabilitation setting using patient based outcome measures as patients find 
these acceptable and they produce results that are reliable and valid.
This study has shown that it is possible to measure physical function and 
emotional wellbeing with a postal survey using patient based outcome 
measures. Assessing patients after discharge using postal questionnaires 
may be an effective way of identifying those patients who are having 
difficulties in the community. In this way, further interventions can be 
provided for patients, such as readmission to the rehabilitation unit, 
outpatient support, or increased community input.
3.4.4 Conclusion
Neurological rehabilitation is effective in improving physical function and 
emotional wellbeing in patients with acute or chronic disability. It is possible 
to measure accurately the changes brought about by rehabilitation 
interventions. However, when patients are discharged to the community, 
emotional wellbeing deteriorates despite maintenance of physical function.
It is possible that incomplete return to a full social role contributes to patients’ 
deterioration in wellbeing after discharge from rehabilitation. The next 
Chapter describes a study that examines the relationship between chronic 
neurological illness and retention of employment, an important social role for 
adults of working age.
Chapter 4 The Impact of MS on Work Retention
4. The Impact of MS on Work Retention
4.1 Introduction
The previous Chapter outlined the impact of inpatient neurological 
rehabilitation on physical function and emotional wellbeing. Most patients 
who are discharged from inpatient rehabilitation programmes after an acute 
neurological illness are able to return to living in the community, and some 
patients are able to resume employment. For these patients, being able to 
return to work, or retrain in a new career, may be a factor in promoting 
emotional wellbeing, as returning to a previous role signals a return to 
normality for most people.
Equally, patients with chronic neurological illnesses living in the community, 
who are in employment, may benefit from rehabilitation interventions to 
improve their ability to remain in work. (Barnes 2003) For this group of 
patients, improved ability to work may also contribute to an enhanced sense 
of wellbeing.
Chronic neurological illnesses include conditions that are progressive in 
nature, such as MS. The needs of patients with MS change over time; 
patients may have disabling relapses with relapsing-remitting MS, or they 
may accumulate disability in progressive MS. In order for people with MS to 
remain in employment, work retention interventions have to be flexible to 
respond to these changes.
Why is work retention so important? First, work is a significant social role. 
(Williams 1987) Most adults of working age define their role in society in 
terms of the work that they perform and disruption of this role by chronic 
illness can alter adult identity. It has been reported that for people with MS, 
“the assault on the identity for many people when they are unable to perform 
as usual can be profound”. (Dyck and Jongbloed 2000)
Second, the combination of loss of paid employment and medical expenses 
can put a considerable economic burden on individuals with chronic 
conditions and on their families. In a study of families in the United States 
where the wage earner had MS, it was reported that 25% of families had 
inadequate means to cover their day-to-day needs, even when the cost of 
medical care was excluded. (Catanzaro and Weinert 1992)
Third, unemployed individuals experience lower quality of life. (Lindholm et 
al. 2002) As a result of the combination of altered social role, financial 
uncertainty and the direct health related effects of the MS itself, quality of life 
in unemployed people with MS is lower than in those who are working and 
have the same level of disability. (Aronson 1997) For these three reasons, 
work retention programmes should be available for people with MS who are 
experiencing difficulties staying in work.
The level of employment amongst people with MS has been uniformly low in 
studies over the last 20 years. Table 4.1 outlines six epidemiological studies 
that have included data on employment. Despite differences in countries and 
methodologies, four of the six studies reported remarkably similar levels of 
employment (23% to 32%).
Table 4.1 Employment in people with MS
Location
(Reference)
Number Mean
age
Duration 
of MS
EDSS Employment
rate
Saxony, Germany 
(Poser 1981)
92 N/A 18.4 N/A 30%
New York, US 
(Larocca 1982)
312 43 13 4.6 23%
Tromso, Norway 
(Gronning 1990)
79 30 N/A N/A 49%
Vancouver, Canada 
(Jackson 1991)
210 45 N/A N/A 24%
Ontario, Canada 
(Aronson 1997)
697 48 12 N/A 32%
Northern Ireland* 
(McDonnell 1998)
111 53 13.6 6.0 14%
* This study only included patients with primary progressive multiple sclerosis 
N/A: Not available
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One of the first studies to examine employment issues in people in MS was 
performed in Lower Saxony in Germany. (Poser etal. 1981) This was a 
cross-sectional study of patients attending an MS clinic, with patients being 
interviewed by medical sociologists and neurologists. Ninety-two of 148 
patients were interviewed with respect to the impact that MS had on their 
employment status. Poser’s study found that impaired mobility, bladder and 
bowel dysfunction, and ataxia were the most common factors that limited 
patients’ ability to work.
The following year, Larocca’s group in New York found that 23% of patients 
selected from an MS clinic were still in employment after a mean duration of 
MS of 13 years. (Larocca et al. 1982) Patients underwent a structured 
interview and examination by a neurologist. Increasing disability was the 
main factor related to unemployment. A one-point increment in Kurtzke 
Disability Status Scale was associated with a 7% increase in the probability 
of being unemployed.
In the Norwegian study, the patients were much younger with a mean age of 
30 years, which explains the higher employment rate. (Gronning et al. 1990) 
This was a retrospective study and data for the study were taken from the 
medical notes of all patients with MS registered with the neurology service of 
a district hospital in northern Norway. Older patients, and those with 
progressive MS, were most at risk of becoming unemployed.
These three studies are limited by only including patients attending hospital 
services. People with MS who were not registered with the hospital, either 
because they were not in need of neurological services or because they 
received their care at other facilities would not have been sampled in these 
surveys. Later studies have used community-based surveys to increase the 
cohort of patients sampled.
Two of these community-based studies involved postal questionnaires. The 
first, Jackson’s 1991 study of unemployment amongst members of the 
Vancouver Island MS Society in Canada, had a 51.6% response rate to a 
single postal questionnaire. (Jackson etal. 1991) The authors note that, 
although they followed Dillman’s advice on the design of the questionnaire 
itself, (Dillman 1978) the study’s funding permitted only one questionnaire 
mailing. Mobility, fatigue and access at the workplace were identified by 
patients as having the greatest impact on their ability to work.
The second community-based study to use postal questionnaires selected 
participants at random from the membership of the Ontario MS Society. 
(Aronson 1997) There was an 83% response rate from 845 people with MS 
initially contacted. Fatigue and mobility problems were again reported to be 
the greatest barriers to work.
In the final study, from Northern Ireland, all of the patients had primary 
progressive MS. (McDonnell and Hawkins 1998) Patients were recruited to
the study as part of a larger epidemiological study of MS in the region. One 
neurologist interviewed and examined all patients and recorded employment 
status. Mean Expanded Disability Status Scale (EDSS) score in patients in 
this group was higher than that recorded for patients in the study by Larocca 
et al, and patients were older than in the other studies, which may explain 
the lower employment rate.
Other studies have reported increased unemployment in association with 
higher disability. (Hammond et al. 1996) Longer duration of MS is also 
related to unemployment, which is likely to be due to the accumulation of 
disability over time. (Jacobs et al. 1999) These findings were confirmed in a 
prospective study of risk factors for unemployment in a cohort of Canadian 
patients of working age who were followed up over a two-year period. 
(Busche et al. 2003) The authors found that employment fell from 51.1% at 
baseline to 40.6% at follow-up. Patients at greatest risk of becoming 
unemployed were older, had progressive MS, greater disability and longer 
duration of MS. The authors recommended targeting interventions to those 
patients at greatest risk of unemployment to improve their chances of 
remaining in work.
These studies have documented the impact that impaired mobility and 
balance, bladder and bowel dysfunction, and fatigue have on patients’ ability 
to remain in work. MS can also have a profound effect on cognitive ability. A 
study of cognition in patients with MS reported that cognitive impairment, in
particular problems with planning and executive dysfunction, was an 
independent risk factor for unemployment. (Rao et al. 1991) This increased 
risk is independent of the patients’ physical impairments. Rao et al. have 
suggested that neuropsychological testing can facilitate work retention by 
allowing appropriate adaptations in the workplace.
A more insidious barrier to employment in patients with MS is the attitudes of 
their employers and co-workers. This has been reported by patients as 
subtle prejudice, in spite of legislation, such as the Americans with 
Disabilities Act, designed to prevent discrimination against people with 
disabilities. (O'Day 1998) Patients in O’Day’s study reported that work 
colleagues would comment unfavourably on their unsteadiness or slurred 
speech, implying that they were drunk. Other patients reported that their 
managers misinterpreted repeated toilet breaks, due to urinary frequency, as 
laziness.
While identifying the factors relating to difficulties in work retention is 
important, it is necessary to quantify them as well, in order to gauge the 
extent of the problem and to plan interventions to alleviate barriers to work. A 
number of authors have attempted to develop questionnaires to measure 
these factors, which are outlined in the next section.
Generic work impact measures: These have been developed to examine 
the relationship between health status and ability to work. The measures
were designed to be used in any sample of workers, irrespective of the 
nature of their employment or their illness. The first generic work impact 
questionnaire to be published, the Work Productivity and Activity Impairment 
measure, aimed to quantify the effect of illness on patients’ ability to perform 
their work roles. (Reilly et al. 1993) It was administered as a self-report 
questionnaire and demonstrated good test-retest reliability and construct 
validity.
The Work Limitations Questionnaire was developed using psychometric 
methods to measure the impact of chronic health problems on work. (Lerner 
et al. 2001) The patients that were included in the group from which the 
items for the questionnaire were generated had a range of chronic medical 
conditions including asthma, inflammatory bowel disease, depression and 
epilepsy. The final 25-item measure had high internal consistency, test-retest 
reliability and construct validity.
Other questionnaires, such as the Work Productivity Short Inventory,
(Goetzel et al. 2003) and the Health and Work Performance Questionnaire 
(Kessler et al. 2003) have attempted to establish the economic impact of 
chronic illness on the employer. These two instruments were specifically 
designed to measure the cost to the employer of chronic illness related 
reduced work ability. They have not been used to measure the impact of 
chronic illness on an individual’s ability to work.
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None of these measures had any items that pe rta in  specifically to the impact 
of neurological illness. This is not surprising as, overall, people with a 
neurological condition form only a small part o f  th e  total population that is 
unable to work because of health related problems. Information from the 
Department of Social Security in the UK indicates that five percent of 
incapacity benefit claimants have a neurological condition; of whom 14% 
have MS. (British Society of Rehabilitation M edicine 2000) Musculoskeletal 
(28%) and psychological (20%) conditions are th e  most common medical 
reasons for patients to claim incapacity benefit. Therefore, a generic 
questionnaire dealing with health related ability to  work would primarily have 
to concentrate on these two areas in order to h a ve  the greatest content 
validity.
Disease-specific work impact measures: A  number of disease-specific 
work impact questionnaires have been published. These have been 
developed to examine the relationship between a specific medical condition 
and patients’ ability to perform their work. Examples include the Work 
Instability Scale for patients with rheumatoid arthritis, (Gilworth et al. 2003) 
and the Fear Avoidance Beliefs Questionnaire-Work for patients with chronic 
pain. (Ciccone and Just 2001) As musculoskeletal problems and chronic pain 
are amongst the most common medical reasons for patients to become 
unemployed, it is not surprising that these issues have been addressed in 
disease-specific measures.
146
There has only been one report of an MS and employment specific 
questionnaire in the literature -  the Work Assessment Scale (WAS). (Gulick 
1991) This is a 52-item questionnaire that asks patients with MS to rate items 
that may impede or enhance their ability to work. It demonstrates adequate 
internal consistency but other forms of reliability and acceptability were not 
tested. Convergent validity was established between the WAS and the 
Activities of Daily Living Self-Care Scale (MS). The author does not present 
any responsiveness data. The WAS has not been used in any subsequent 
publications.
To measure the impact of MS on patients’ ability to retain work, the following 
study was undertaken. The first phase was a qualitative study that aimed to 
identify the areas that impact on work retention in patients with MS. The aim 
of the second part was to quantify the physical, psychological and social 
factors affecting work retention in a cross-sectional sample of patients with 
MS, based on the information collected in the first phase.
The Joint Research Ethics Committee of the National Hospital for Neurology 
and Neurosurgery and the Institute of Neurology approved the study. All 
patients gave their informed written consent.
4.2 Qualitative Study
4.2.1 Methods
All patients with clinically definite MS, attending the National Hospital for 
Neurology and Neurosurgery, aged 18 to 65 years, were eligible to 
participate in the study. Patients were recruited from an MS outpatient clinic 
and the inpatient rehabilitation unit of the hospital to ensure a wide age 
range, duration of MS, and range of disabilities.
Patients were asked about their MS, their experiences of employment and 
their social circumstances. This interview was supplemented by completion 
of a questionnaire comprising open-ended questions regarding the effect that 
MS had on ability to remain at work. Demographic information was obtained 
during the patient interview and from the medical notes. The results of 
patient interviews and questionnaires were entered into a database and 
content analysed. Areas relating to work retention were identified.
4.2.2 Results
Sample: Sixty-two patients participated in the first phase of this study. Fifty- 
three patients were attending outpatient clinics and nine were inpatients in 
the NRU who had been admitted from home for a short period of inpatient 
rehabilitation. The mean age of the patients was 46 years and ranged from 
19 to 65. Forty patients (65%) were female. All patients had clinically definite
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MS with a mean duration of 12 years (range one to 43 years). Twenty-four 
patients (39%) were employed at the time of the interview.
The open-ended items of the questionnaire generated a list of problems that 
the patients found impacted on work retention. These problems could be 
divided into those relating to: the person and their disease; and societal and 
employment environments. The two themes can be illustrated by examples 
from the questionnaire.
The person and their disease: Patients often described a particular 
problem that had a major impact on their ability to remain in work and that 
concerned them a great deal. For example, a 49-year-old woman with MS for 
19 years who had recently become unemployed from an office job stated:
“This illness has devastated my life and the way I deal with things. My 
main concern is my bladder problems.”
At times, a specific problem was cited as creating difficulty with work 
retention, such as poor vision or ataxia, which impacted on the ability to use 
particular equipment. For example, a 48-year-old female who had worked as 
a civil servant commented on her ability to use the mouse of a computer:
“I would have liked to work 10 to 12 hours a week, but my hand-eye 
co-ordination was too poor.”
At other times, it was a symptom of MS that impacted on all activities, both in 
work and at home. For example, this 45-year-old male patient with MS for 13 
years had worked as a social worker until five years ago:
“Normal daily things take so long unfortunately. I get very fatigued 
very quickly.”
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By contrast, other patients reported having flexible working environments 
that allowed them to take time-off if they were unwell. For example, one 
patient was able to work from home on days that he was particularly 
fatigued. Fatigue could lead onto other problems with work retention, such as 
depression or anxiety, as well as being an issue in itself. This is illustrated by 
a 42-year-old female’s comment:
“I feel very tired in the afternoons. I feel a burden on people in work.”
Societal and employment environments: The difficulties identified most 
were travelling to and from work, and access at work. This is highlighted by a 
42-year-old male quantity surveyor with MS for 12 years who commented on 
the effect that reduced ability to perform physical tasks had in his particular 
work environment:
“My concern revolves around my ability to undertake certain tasks 
such as walking, climbing ladders and stairs. I therefore need to learn 
to delegate to others and am slowly coming to terms with this.”
Another example comes from a 48-year-old female patient with MS for 15 
years who related that, after the last relapse that resulted in her having to 
use a wheelchair to mobilise in the community, she was unable to return to 
work because of access problems:
“I did try to resume work, but was told I couldn’t, as the wheelchair 
couldn’t be lifted up four steps to get in.”
Other patients found the travelling to and from work was too difficult, even if 
they had access to private transport. For example, a 51-year-old solicitor 
who had MS for eight years stated:
“I travel by minicab as I can’t use public transport so I only go to the 
office twice a week.”
Even using adaptive equipment may not be a completely satisfactory solution 
to these problems. For example, a 54-year-old male architect reported that 
he found it increasingly difficult to use voice-activated software, and in order 
to retain his work, he now required a support worker, who was funded by the 
Access to Work scheme.
The areas relating to the person and their disease, and societal and 
employment environments were grouped into a one page, self-report 
questionnaire (Appendix 4). These items were supplemented by additional 
themes from work and MS related articles identified by a search of Medline 
from 1966 to 2003 and Web of Science from 1981 to 2003. The items could 
be represented with the common stem “how much does the following impact 
on your work”, with a five-point response option scale. (Streiner and Norman 
1995) This adjectival scale rated the impact of each item -  from no impact 
(one) to extreme impact (five). With this measure, scores can range from 17 
to 85; higher scores indicate greater impact of MS on work retention.
4.3 Quantitative Study
This section describes the methods of the second part of the study. The main 
aim of this part of the study was to quantitatively evaluate the impact of MS 
on work retention. The impact on work questionnaire, as outlined in the 
previous section, was used in this study to measure the impact of MS. 
Measures of physical function (self-report Barthel index) and emotional 
wellbeing (GHQ-28) were also recorded to relate work retention issues to
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these factors. As a secondary aim, the psychometric properties of the impact 
on work questionnaire were studied.
4.3.1 Methods
Sample: One hundred patients with clinically definite MS, aged 18 to 65 
years, attending an MS outpatient clinic, were invited to participate. 
Demographic data, including type and duration of MS, were recorded for 
each patient.
Outcome measures: Each patient was asked to complete a questionnaire 
booklet that contained the impact on work questionnaire and questions on 
employment status, previous or current occupation and sources of advice 
that the patient had accessed. The design of the booklet was based on 
Dillman’s “Total Design Method”, as outlined in Chapter 1, to ensure the 
greatest response rate. (Dillman 1978) The booklet also included the self- 
report Barthel index and the GHQ-28 to record physical function and 
emotional wellbeing, as described in the previous Chapter. Patients were 
also encouraged to add any further information they wished to contribute in a 
comment box in each booklet. In addition, the Expanded Disability Status 
Scale (EDSS), a clinician rated MS disability measure, was recorded for 
each patient to allow comparison of the patients in this study with other 
studies. (Kurtzke 1983)
Statistical methods: Summary statistics were examined for the group as a 
whole, and subgroup analyses were performed for employed and 
unemployed patients. The demographic data -  age and duration of MS -  
were compared using independent f-tests, as were the Barthel index, GHQ- 
28 and EDSS scores. The scores for the items of the impact on work 
questionnaire were summated and also compared using parametric 
statistics.
Psychometric methods: The items of the impact on work questionnaire 
were tested for patient acceptability by calculating percentage missing data. 
Acceptability was also evaluated by determining scale and item means, 
standard deviations, and endorsement frequencies for each response option 
of the rating scale.
To determine reliability, the items of the questionnaire were first entered into 
a factor analysis of principal components to extract the factors that might 
explain the constructs measured by the scale. Solutions with Eigenvalues 
greater than one were chosen in order to select the number of factors to 
rotate in varimax principal axis factoring. (Staquet et al. 1998) This technique 
reduces the amount of variance in each factor by including only the smallest 
possible number of items in each factor. Principal axis factoring rotation was 
performed for each of the potential solutions suggested by principal 
component analysis. Each rotated solution was then examined for items that
loaded with each other by more than 0.40 to develop subscales of the 
questionnaire.
It was assumed that each subscale would measure a distinct but related 
construct of the impact that MS has on work retention. To examine how well 
each subscale measured a particular construct, the internal consistency of 
the subscales were calculated using Cronbach’s alpha coefficient and item- 
total correlations. Alpha values should be greater than 0.70 and item-total 
correlations should be greater than 0.20 to support the internal consistency 
of the subscale. (Streiner and Norman 1995)
Validity was studied to ensure that the questionnaire measured the construct 
it purported to measure. Construct validity was measured using Pearson’s 
correlation coefficients between the questionnaire’s subscales and other 
variables. It was expected that the subscales of the questionnaire would 
correlate moderately with each other (r = 0.30 to r  = 0.70). It was also 
expected that there would be moderate correlations between the subscales 
and the measures of physical disability (EDSS, Barthel index) and emotional 
wellbeing (GHQ-28). While these instruments measure specific constructs in 
MS, they will not fully explain the impact of MS on work retention. Given that 
the questionnaire was designed to be a measure of the impact of MS on 
work retention, unemployed patients were expected to have higher scores 
than employed patients.
4.3.2 Results
Sample: One hundred patients participated in the cross-sectional study: 36 
were employed and 64 were unemployed. The patients’ demographics are 
presented in Table 4.2. Results of demographic data and outcome measure 
scores are compared between employed and unemployed groups using 
independent sample Mests, and the level of statistical significance is 
included.
Outcome measures: In this sample, the patients who were unemployed 
were older, had a longer duration of MS, and lower Barthel index scores and 
had higher EDSS scores (both indicating greater physical disability) than 
patients in work. There were significantly more patients with secondary 
progressive MS in the unemployed group. There was no difference in scores 
for emotional wellbeing on the GHQ-28 between the two groups.
Table 4.2 Demographics of patients in quantitative study
Variable (SD; range) Employed Unemployed Significano
Number 36 64
Age 45 (8; 27 - 59) 49(10; 20-65) p < 0.05
Female (%) 25 (69%) 50 (78%) NS
Type of MS
Primary progressive MS 7 8
Relapsing-remitting MS 14 12
Secondary progressive MS 13 44 p < 0.05
Duration of MS 10(7; 0 -2 2 ) 15(8; 1 -43) p<0.01
EDSS 5.7 (1.8; 1.5-8.0) 6.8 (1.6; 1.0-9.0) p<0.01
Self-report Barthel index 17 (4; 1 -20) 12 (5; 1 -20) p <  0.01
GHQ-28 score 6 (7; 0 - 23) 5 (6; 0 - 25) NS
GHQ-28 depression case (%) 17 (47%) 24 (37%) NS
Impact on work questionnaire 43(14; 25 -69) 48(12;26-71) p = 0.07
Twenty-four employed patients reported that MS affected their ability to 
remain in work. Of the 12 who felt that it did not currently affect their ability to 
remain in work, four felt that it might impact in the future. Forty-three 
unemployed patients stated that they had left work as a direct consequence 
of MS. The other patients either took early retirement or left work to look after 
children. Whether MS influenced these patients’ decisions was not recorded. 
Thirty-three of the unemployed patients expressed a desire to return to work 
if this was possible.
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Only 20 patients reported receiving advice on work retention (Table 4.3). 
Most patients in this group felt that they benefited from talking to hospital 
occupational therapists about their employment issues. The four patients 
who spoke to disability employment advisers in Jobcentres stated that they 
found their advice of limited help. No patient reported receiving employment 
advice from a community-based therapist, a rehabilitation physician or a 
neurologist.
Twenty-three employed patients and 13 unemployed patients recorded that 
they would like to receive advice on work retention (Table 4.3). This group of 
patients included some of those who had received advice before and found it 
of limited help.
Table 4.3 Impact of MS on work retention
Employment status Employed Unemployed
Total number of patients 36 64
MS affects ability to work (%)
MS will affect work in the future (%) 
Left work due to effects of MS (%) 
Would like to return to work (%)
24 (67%) 
4(11%)
43 (67%) 
33 (52%)
Sources of advice on work retention 
Hospital occupational therapist 
Jobcentre
Other patients with MS 
Would like advice on work retention (%)
5
1
1
23 (64%)
7
3
3
13 (20%)
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All patients in the cross-sectional study had been in employment or full-time 
education at the time of diagnosis of MS. At the time of the survey, 
unemployed patients had longer durations of illness than employed patients. 
Figure 4.1 illustrates the effect of increasing duration of MS on patients’ 
ability to remain in work. Unemployment occurred within the first year after 
diagnosis for some patients and increased steadily with increasing duration 
of MS.
Figure 4.1 Duration of MS and work retention
TD
<D
O
Cl
E
<D
(/)
00
c(1)
CD
CL
O
co
t r  o
Q .o
CL
0.0
45402520
Duration of MS (years)
158
Impact on work questionnaire: Working and unemployed patients reported 
similar levels of difficulty in work retention as measured by the questionnaire. 
Using the work impact questionnaire, patients identified the areas that most 
impacted on their ability to work (Table 4.4). Six items were identified by 
more than 25% of patients as having a large impact on their ability to work. 
Four of these areas related to the direct effects of MS: handwriting (26%), 
fatigue (28%), balance (40%) and walking difficulties (45%). Two areas 
related to the impact of societal and employment environments, access at 
work (39%) and travel to and from work (48%).
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Table 4.4 Endorsement frequency: impact on work questionnaire
Item Percentage of patients
Not at all A little Moderately Quite a bit Extremely
Fatigue 6.2 12.4 22.7 30.9 27.8
Balance 15.2 17.2 11.1 16.2 40.4
Walking difficulties 10.3 9.3 11.3 23.7 45.4
Visual problems 40.8 23.5 9.2 14.3 12.2
Weakness 7.1 25.3 26.3 26.3 15.2
Handwriting 24.2 12.1 10.1 27.3 26.3
Pain 38.4 25.3 11.1 16.2 9.1
Coordination 21.2 25.3 24.2 18.2 11.1
Speech 65.7 15.2 7.1 7.1 5.1
Swallowing 74.7 16.2 6.1 2.0 1.0
Continence 23.2 32.3 14.1 16.2 14.1
Concentration 26.8 39.2 11.3 16.5 6.2
Memory 36.7 31.6 13.3 12.2 6.1
Mood 37.8 26.5 24.5 10.2 1.0
Travel to work 11.6 13.7 15.8 10.5 48.4
Access at work 12.5 20.8 9.4 18.8 38.5
Public attitudes 36.7 22.4 16.3 16.3 8.2
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Psychometric analysis: There was a low proportion of missing data for all 
items of the impact on work questionnaire suggesting that all of the items 
were acceptable to patients (Table 4.5). Examination of scale and item 
means, standard deviations and item endorsement frequencies showed that 
responses were generally well distributed across all response categories.
Table 4.5 Acceptability: impact on work questionnaire
Environment scale Symptom scale
Items
Missing data 1% - 4%
Mean scores: range 1.38 - 3.85
SD: range 0.78-1.55
Floor effect: range 7.1% - 74.7%
Ceiling effect: range 1.0% - 48.4%
Subscales
Possible score range 5 - 4 0  5 - 45
Observed score range 8 - 3 7  14-44
Mean score (SD) 29.2(8.3) 17.0(6.9)
Floor/ceiling effect 0% / 0% 4% / 0%
Factor analysis indicated a two-factor solution: a symptom scale, comprising 
items that referred to the person and their disease theme; and an 
environment scale, that referred to items relating to mobility and access 
(Table 4.6). Items loaded to one of the two factors by more than 0.40 for all 
but two items -  continence and pain. The values for these items were 0.359 
and 0.397 respectively. As incontinence and pain are clinically important 
symptoms in MS, it was felt that these two items should be retained in the 
measure.
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Table 4.6 Factor loading: impact on work questionnaire scales
Item
Environment scale 
Walking difficulties 
Balance 
Access at work 
Travel to work 
Weakness 
Public attitudes 
Handwriting 
Continence
Symptom scale 
Concentration 
Memory 
Speech 
Swallowing 
Visual problems 
Coordination 
Mood 
Pain 
Fatigue
Environment scale Symptom scale
0.808
0.793
0.730
0.726
0.708
0.588
0.498
0.359
-0.095
0.104
0.131
0.090
0.316
0.047
0.337
0.285
0.152 
0.169 
0.137 
0.148 
0.040 
0 406 
-0.027 
0 349 
0.406
0.834
0.812
0.799
0.754
0.716
0.662
0.638
0.397
0.388
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The two subscales of the impact on work questionnaire were then examined 
for internal consistency by calculating Cronbach’s alpha coefficients and 
item-total correlations (Table 4.7). The subscales met the criteria for both of 
these tests indicating satisfactory internal consistency.
Table 4.7 Reliability: impact on work questionnaire
The intercorrelations between the total and subscale scores of the impact on 
work questionnaire are presented in Table 4.8. All correlations are high 
indicating that the questionnaire and its subscales are measuring related 
constructs. The two subscales correlate moderately with each other 
suggesting that they measure related but distinct constructs.
Correlations between the environment scale and the Barthel index and 
EDSS index are moderate and correlations between the symptom scale and 
the Barthel index and EDSS are low (Table 4.8). There is a low correlation 
between the environment scale and the GHQ-28. Age is not correlated with 
either subscale. These results provide evidence of convergent and 
discriminant validity.
Environment scale Symptom scale
Reliability 
Cronbach’s alpha 
Item-total correlations: range
0.84 
0.354 - 0.693
0.87 
0.420 - 0.729
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Table 4.8 Intercorrelations between questionnaire scales
Variable Environment scale Symptom scale
Total score 0.891 0.841
Environment scale 0.504
EDSS 0.403 0.104
Barthel index -0.395 -0.151
GHQ-28 0.135 0.256
Age 0.116 -0.144
When the scores for the environment and symptom scales were examined, a 
statistically significant difference was noted between working and 
unemployed patients on the environment scale: 45 and 62 respectively (p 
<0.001). There was no statistical difference between the groups of patients 
on the symptom scale: 30 and 27 respectively. This result provides evidence 
of group differences construct validity of the environment scale.
4.4 Discussion
4.4.1 Summary of Results
For the patients with MS in this study, work represents an important social 
role that they enjoy and wish to engage in for as long as possible. Three 
factors were elucidated to explain the impact of MS on work retention. The 
first is the pervasive effect that MS has on patients’ ability to retain work. The 
second is the interaction between patients’ physical limitations and barriers in 
the environment, either an inaccessible workplace or the lack of suitable
transport. The third is the impact of poor vocational support on patients’ 
ability to find solutions to work retention issues.
The first of these factors, the effects of the disease process, varied in its 
impact on work retention. Some symptoms of MS, for example, balance or 
walking difficulties had a large impact on work retention. Others, such as 
mood or memory, had a much smaller impact. These results are similar to 
those seen in two studies of community-based populations of patients with 
MS in North America. (Gulick et al. 1989; Jackson et al. 1991) No other 
authors have looked at specific impairments impacting on work retention.
This study found that increasing age, longer duration of MS and accrual of 
disability are associated with increased difficulties in retaining work. These 
results are similar to those found in studies from other centres in Europe and 
North America. (Gronning et al. 1990, Larocca et al. 1985, Poser et al. 1981) 
Patients in this study with secondary progressive MS, as in other studies, 
were also more likely to be unemployed. (Jacobs et al. 1999)
The second factor was the interaction between limitations in patients’ 
physical ability and barriers in the environment, such as travelling to work 
and accessing it once there. Patients in Gulick’s study reported that the 
combination of limitations in walking, standing and balance, and physical 
barriers in the environment, had the greatest impact on their ability to work. 
(Gulick et al. 1989) Other studies have also explored the work environment
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in job retention. Twenty percent of the patients in the study by Jackson 
identified inaccessible toilets as having a large impact on their ability to 
remain in work. (Jackson et al. 1991) In this study, the continence item 
loaded with the environment scale on factor analysis, indicating that 
incontinence may not be a work limiting problem as such, except when 
accessible toilet facilities are not available.
Conversely, an accessible environment, with appropriate adaptations and a 
flexible work pattern can assist patients in remaining in work. A case- 
controlled study of protective factors in work retention identified that 
sedentary jobs, where the patient was able to do his or her work in a sitting 
position, were the jobs most likely to be retained by people with MS. 
(Verdier-Taillefer et al. 1995) Gulick’s study also described conditions that 
enhanced the ability to remain in work including adaptive aids, intermittent 
rest periods and the ability to pace one’s work. (Gulick et al. 1989)
The third factor was the availability of good vocational support. Only 20% of 
patients in this study had received any advice on work retention. Most of this 
advice had been given by hospital occupational therapists. The lack of 
assistance from statutory employment agencies has been reported in other 
studies. Patients in the study by O’Day described a lack of understanding for 
the needs of patients with MS from vocational rehabilitation officers. (O'Day 
1998) Frequently, however, patients are not referred to any vocational 
rehabilitation service, even if the assistance offered is less than optimum.
(Roessler and Rumrill, Jr. 2003) The support required by patients can often 
be minimal, generally comprising the ability to take rests or installing 
adaptive aids in the workplace. (Gulick et al. 1989)
This is the first study in the UK to explore the issues surrounding work 
retention in patients with MS. A combination of MS-related problems, 
environmental and travel restrictions, and lack of vocational support impact 
on work retention.
4.4.2 Study Strengths and Limitations
This study included patients with a wide age range, representative of the 
population of adults of working age. There were more females than males, 
as expected in a cohort of patients with MS. All subtypes of MS were 
represented and there was a wide range of duration of MS. Patients in this 
study had similar demographic and disease characteristics to those in the 
other studies on work and MS outlined above. This supports the 
generalisability of these results.
This study is limited, however, by only recruiting patients who were attending 
the NHNN. This study did not include patients who had no contact with 
hospital services. This may bias the results by including patients with greater 
disability. Furthermore, patients in this study all lived in the Greater London 
area. This might have biased their opinion of the impact of travel on their
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ability to remain in work. Lack of parking facilities and inaccessible public 
transport are two problems encountered by all patients with MS in any large 
urban area.
With respect to the data collection, this was a cross-sectional study, so it was 
not possible to determine the impact of the various factors that impacted on 
work retention over time. Factors leading to problems in work retention have 
been studied by other authors, who have established that the most important 
determinants of loss of work are increasing disability and older age. (Busche 
et al. 2003)
Finally, due to the cross-sectional design of this study, it was not possible to 
study the test-retest reliability or responsiveness of the impact on work 
questionnaire. These properties remain to be tested.
4.4.3 Implications for Clinical Practice
These results have important implications for the management of patients 
with MS. As seen in other studies, patients with MS have difficulty with work 
retention. There are three areas that clinicians need to address to assist 
patients with MS in remaining in work.
Firstly, work retention is significantly affected by impairments caused by MS, 
particularly mobility and fatigue. Appropriate management by outpatient and
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community multidisciplinary teams, but including if necessary a period of 
inpatient rehabilitation, has a role to play in reducing the impact of MS- 
related impairments. Both the physical (Busche et al. 2003) and the cognitive 
impairments of MS (Rao et al. 1991) need to be addressed for a 
comprehensive approach towards work retention.
In this study, loss of work occurred soon after diagnosis for some patients, 
indicating the importance of implementing work retention strategies 
immediately after diagnosis. As MS can be a fluctuating illness initially, it is 
crucial that patients are able to take sick leave during relapses, with support 
to return to work as soon as is feasible. This has been shown to be 
protective in work retention studies. (Verdier-Taillefer et al. 1995) With 
progressive forms of MS, work retention strategies need to be flexible to 
adapt to the changing needs of the patient with MS.
The impairments caused by MS become limitations on participation in work 
when they impact on a patient’s ability to travel to and from work, access the 
workplace and have access to a suitable toilet. This leads onto the second 
area that clinicians need to address. Mobility was identified as having a large 
impact on work retention, so rehabilitation to improve walking, or prescribing 
an appropriate mobility aid may improve work retention. Providing a suitable 
work environment that is accessible and has appropriate equipment is the 
remit of Jobcentre Plus in the UK. Unfortunately, patients in this study had
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very little contact with Jobcentre Plus, or its predecessor, the Disability 
Employment Agency.
Thirdly, as studies have shown that vocational services can be unresponsive 
to the needs of patients with MS, clinicians need to work closely with these 
services to improve their interactions with patients. (O'Day 1998) Improving 
the link between clinicians and vocational services is a key element in 
Government strategy to reduce the number of people on incapacity benefit in 
the UK (Secretary of State for Work and Pensions 2002)
These three areas lend themselves to collaboration between clinicians, 
working in a multidisciplinary team with occupational therapists and 
physiotherapists, and disability employment advisers in Jobcentre Plus. A 
model of vocational rehabilitation could be adopted from examples of good 
practice in low back pain or traumatic brain injury. (Bendix et al. 1998; 
Wehman et al. 2003) These services comprise a multidisciplinary team that 
includes an occupational psychologist. They offer a range of services that 
includes “job-coaching", or on-the-job support, to facilitate the incorporation 
of work retention strategies and adaptive equipment into a patients’ 
workplace.
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4 .4.4 Conclusion
This study represents the next step in the patients’ journey from acute 
neurological illness to recovery -  return to work. This study outlines how 
patients with MS need both good medical management and vocational 
rehabilitation to reduce the impact that MS has on work retention. This study 
has also shown that the impact of MS on work retention can measured using 
a short questionnaire.
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Chapter 5 Conclusion
5.1 Summary of Findings
Neurological rehabilitation is a complex intervention requiring significant 
healthcare resources and considerable involvement of patients, their families 
and carers. It is incumbent upon rehabilitation teams to employ the most 
effective interventions to enable patients with neurological conditions to live 
as independently as possible. Measuring outcome is the first step in 
determining the effectiveness of an intervention. The measures used for 
evaluating outcomes must be clinically relevant and scientifically sound. In 
particular, outcome measures used to evaluate interventions must be 
responsive. Because of the importance of responsiveness, specific attention 
was paid to it in this Thesis.
This Thesis has addressed three objectives, which are important points on 
the journey of a patient from the onset of neurological illness, through 
rehabilitation and into the community. The first experience of outcome 
measurement for many patients with disability due to neurological illness is 
on admission to a rehabilitation unit. Therefore, the first objective was to 
comprehensively examine the responsiveness of two outcome measures 
commonly used in neurological rehabilitation, the Barthel index and the FIM. 
This study included a comparison of the responsiveness of these measures 
in MS, stroke and spinal cord injury.
There is considerable evidence that a period of inpatient rehabilitation 
improves physical function and emotional wellbeing, but relatively few
studies have examined the long-term outcome of patients after discharge.
The second objective of the Thesis was to evaluate the effect of neurological 
rehabilitation on these parameters, and to determine if this effect endured 
after discharge. This study incorporated an assessment of the psychometric 
properties of the self-report Barthel index, General Health Questionnaire and 
Hospital Anxiety and Depression Scale.
The next stage on the journey towards recovery for many patients is their 
return to employment. This is influenced by a variety of physical, 
psychological and environmental issues. The third objective of this Thesis 
was to investigate the impact of neurological illness on the ability of patients 
with MS to remain in work. This study also involved the development and 
psychometric testing of an outcome measure to quantify the impact of a 
patient’s illness and work environment on his or her ability to remain in work.
Examining the responsiveness of the Barthel index and FIM demonstrated 
that the total scores are responsive. However, item responsiveness varies 
and is limited by item floor and ceiling effects. Floor effects indicate that there 
were patients who might have improved more than the item detected. Ceiling 
effects represent patients who could not improve their score, irrespective of 
any clinical improvement, as they had already attained the highest score 
possible. Differential responsiveness was also seen between MS, stroke and 
spinal cord injury. Therefore, total score responsiveness needs to be 
interpreted with caution as the total score may be an underestimate of the
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overall effectiveness of neurological rehabilitation. These findings emphasise 
the importance of targeting the range of measurement of a scale to the 
patients being measured.
The second investigation, a prospective, observational study, supported the 
view that physical function and emotional wellbeing are improved in patients 
with acute and chronic neurological conditions, by inpatient multidisciplinary 
rehabilitation. Following discharge, the improvements in physical function are 
maintained, but emotional wellbeing deteriorates. This study also 
demonstrated that the self-report Barthel index, the GHQ-28 and HADS are 
acceptable, reliable, valid and responsive measures in neurological 
rehabilitation.
Lastly, three factors were found to impact on work retention; the effects of 
MS, difficulties within the workplace environment, and poor vocational 
support. These three factors are interrelated, and their effects could be 
mitigated by closer collaboration between health and vocational services. 
The Work Impact Questionnaire demonstrated good acceptability, reliability 
and validity.
5.2 Implications for Rehabilitation Research
The individual studies that comprise this Thesis have used a combination of 
clinician rated and patient based outcome measures. These outcome
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measures have facilitated retrospective, prospective and cross-sectional 
evaluations of the rehabilitation process. The findings of this Thesis can be 
used as a basis to plan further research into neurological rehabilitation 
interventions, and to refine the use of outcome measures in rehabilitation 
studies. This section will consider the points raised by this Thesis with regard 
to the use of patient based outcome measures in rehabilitation studies, 
questionnaire administration, and the psychometric factors relevant to 
outcome measurement.
There is an important conceptual issue in using patient based outcome 
measures to evaluate rehabilitation outcome. As discussed in Chapter 1, 
seeking patients’ opinion on their health status is increasingly emphasised in 
healthcare. (Wilson and Cleary 1995; Higginson and Carr 2001) Using 
patient based outcome measures, particularly those concerned with health 
related quality of life, improves the ability of a trial to detect a clinically 
significant difference, as patients will report changes that may not be 
determined by clinician rated measures. For instance, the GHQ-28 and 
HADS were shown to be clinically useful, as well as responsive, in detecting 
significant changes in patients in rehabilitation. Trials of rehabilitation 
interventions could include these measures to gain a more comprehensive 
picture of the impact of rehabilitation on the psychological aspect of 
neurological illness. Many authors recommend sampling a number of health 
constructs in trials to fully understand the effect of the intervention. (Bergner 
and Rothman 1987; Ware, Jr. 1987) This Thesis has shown that this can be
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achieved for inpatient (Chapter 3) and community samples (Chapter 4) using 
self-report questionnaires.
Furthermore, outcome measures of physical function and emotional 
wellbeing can be used successfully in cross-sectional, and longitudinal or 
evaluative studies, with satisfactory patient recruitment and retention.
Patients with restricted ability to travel due to neurological illness find it 
difficult to attend hospitals to participate in trials; gathering information using 
postal questionnaires could be a potential alternative to bringing patients to 
hospital to score clinician rated scales. There is also a cost advantage in 
postal outcome measures over the alternative of requiring clinicians to travel 
to patients’ homes to complete outcome measures.
To put this into perspective, in Chapter 2, 93% of patients had a complete set 
of clinician rated outcome measures at discharge. In Chapter 3, there was a 
93% response rate to a set of patient based outcome measures completed 
three months after discharge and returned by post to the hospital. Whilst 
these are very different scenarios, a retrospective audit and a prospective 
observational study, it does demonstrate the ability of postal patient based 
outcome measures to gather useful data from a sample of patients with 
restricted mobility. The utility of postal questionnaires should be considered 
when planning a study that requires patients to be followed-up over an 
extended period of time in the community.
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Response rates to questionnaires are enhanced when patients find them 
acceptable. Measuring patients’ opinions in healthcare evaluation is 
important, but an inappropriate patient based outcome measure can be 
worse than none at all, as measures with poor acceptability to patients can 
cause emotional distress in vulnerable individuals. (Evans et al. 2002)
Statistical acceptability is also a key factor in outcome measurement, but is 
rarely discussed in relation to a particular instrument. When selecting a 
measure for use in a trial, careful consideration should be given to choosing 
one that has been tested in a sample with similar characteristics to the 
sample in the proposed study. This will ensure that floor and ceiling effects 
are minimised, reducing the possibility of a false negative effect.
Content validity should also be considered when selecting an outcome 
measure to use in a clinical trial. In Chapter 4, it was demonstrated that 
standard measures of physical function and emotional wellbeing were not 
sufficient to describe the impact of MS on work retention. Patients’ responses 
to an open questionnaire described issues that related to a variety of issues, 
including community mobility, accessible toilets, and fatigue, which were not 
included in the standardised measures. Development of a bespoke 
questionnaire allowed these constructs to be measured. This does not imply 
that a new outcome measure should be developed whenever a study or trial 
is being considered. Organisers of trials should carefully evaluate available
outcome measures, and select those that accurately reflect the construct to 
be measured.
The responsiveness of the total scores of the clinician rated Barthel index 
and FIM has been discussed in Chapter 2. Although it was already known 
that these measures were responsive in MS and stroke rehabilitation 
(Sharrack et al. 1999; van der Putten et al. 1999), the analyses in this Thesis 
have refined the recommendations for their use. The limitations on the 
measures’ responsiveness must be borne in mind if the Barthel index and 
FIM are to be used in trials of neurological rehabilitation. Essentially, this 
means that the measure used should match the level of disability in the 
sample to be studied. This study has also shown that the Barthel index and 
FIM are more responsive in stroke and spinal cord injury than in MS. This 
means that if evaluating an intervention in patients with MS, consideration 
should be given to using a more responsive measure, such as the MSIS-29. 
(Hobart et al. 2001a)
Knowing the responsiveness of a measure can facilitate planning studies 
using the criteria set out by Cohen. (Cohen 1992) This ensures that optimum 
sample sizes are selected, without recruiting fewer patients than would give 
a clinically significant result, or more patients than is necessary. (Briggs 
2000)
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Considering the points raised by the studies in this Thesis, it is advisable to 
obtain as much information as possible about a measure, and how it should 
be administered, before using it in a trial of a rehabilitation intervention. It 
would be important to review previous studies utilising the measure, 
psychometric studies, and head-to-head comparisons of the measure with 
other instruments.
5.3 Future Directions
The previous section has outlined how using appropriate outcome measures 
with satisfactory psychometric properties in properly designed trials can 
improve the evidence base of rehabilitation practice. Rehabilitation has a 
short history as a distinct medical speciality compared to other fields, but it is 
evolving rapidly. Outcome measurement has been closely associated with 
rehabilitation and considerable progress has been achieved in some areas, 
for instance, the development and promotion of the FIM as a universal 
outcome measure, but more work is required. This section explores what 
additional investigations need to be done to improve rehabilitation practice 
and further the scientific measurement of rehabilitation outcomes as a result 
of the studies in this Thesis.
An important finding of this Thesis has been the changes in emotional 
wellbeing that patients experience at different points in their rehabilitation 
programme. Most authors examining health related quality of life in patients 
with neurological conditions have focused on patients recently diagnosed
with a particular illness. A smaller proportion of studies has evaluated the 
impact of rehabilitation on quality of life and even fewer has looked at 
patients’ wellbeing after discharge. Further studies are required to consider 
this critical area, to ensure that anxiety and depression do not impede 
patients’ recovery.
Future work should examine the factors that lead to the deterioration in 
psychological functioning that accompanies discharge into the community 
from rehabilitation programmes. In particular, provision of community based 
rehabilitation should be enhanced. There is evidence that community 
services for people with chronic disability are inadequate, with a significant 
proportion of patients with moderate (39%) and severe disability (12%) not 
having access to any community nursing or therapy support. (Freeman and 
Thompson 2000) Several studies have demonstrated the effectiveness of 
community rehabilitation in improving physical functioning and emotional 
wellbeing in MS, (Wiles et al. 2001) stroke, (Andersen et al. 2002) and 
Parkinson’s disease. (Trend et al. 2002) However, the evidence base for 
community rehabilitation should be enhanced by further studies of outpatient, 
day-care and home-based rehabilitation programmes.
Irrespective of the availability of community rehabilitation, inpatient 
rehabilitation units should adopt strategies to protect patients’ emotional 
wellbeing after discharge. Emotional recovery is facilitated by ensuring that 
patients have the necessary abilities to lead as independent life as possible
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after discharge. (Kreutzer and Kolakowsky-Hayner 1999) Kreutzer’s study 
describes the importance of providing patients with communication and 
problem solving skills to maintain their emotional wellbeing, and this area 
requires further evaluation to determine the optimum methods of enhancing 
psychological functioning.
Participation in employment is another area highlighted in this Thesis that 
should be explored by future investigations. Only patients with MS were 
studied, but other patients with chronic neurological conditions will share 
their experiences of trying to remain in work. The technique used in Chapter 
4 could be adopted for other patient groups, including those who have had 
an acute onset of disability and are trying to return to work.
The impact of chronic neurological illness on patients’ ability to work needs to 
be examined in greater detail. Chapter 4 has outlined the three main factors 
that impact on work retention -  the symptoms of MS, accessible work and 
transport, and vocational rehabilitation services. Each of these factors needs 
to be addressed by the introduction of a range of services and a dedicated 
work retention multidisciplinary team that includes personnel from the 
Department of Work and Pensions. (Secretary of State for Work and 
Pensions 2002) For each patient who is unable to remain in work due to the 
impact of a chronic neurological condition, an individualised work retention 
programme should be instituted. This may include adaptive equipment,
facilitation of skills in the workplace by occupational therapists, or time 
management strategies by an occupational psychologist.
Work retention interventions should be assessed for effectiveness to improve 
the evidence base for vocational rehabilitation programmes. The impact of 
these interventions could be measured by patient based outcome measures, 
or econometric instruments such as the Work Productivity Short Inventory, 
(Goetzel et al. 2003) and the Health and Work Performance Questionnaire. 
(Kessler et al. 2003) These last two instruments were specifically designed to 
measure the cost to the employer of chronic health conditions and, in 
combination with information regarding the patients’ perspective on work 
ability, could be used to make a strong case for work retention strategies that 
have demonstrated their effectiveness.
In neurological rehabilitation the Barthel index and the FIM are two of the 
most commonly used clinician rated outcome measures. The study 
described in Chapter 2 on the responsiveness of these measures was 
performed on the outcomes recorded by one neurological rehabilitation unit 
in London over a ten-year period. These analyses need to be performed on 
data from rehabilitation units in other centres to confirm the results. It would 
also be instructive to compare the differential item responsiveness of these 
measures in other diagnostic subgroups, for instance, traumatic brain injury, 
sub-arachnoid haemorrhage or Parkinson’s disease. Analysis of the 
responsiveness of the Barthel index and FIM in these groups may reveal
other items that perform poorly and require attention when the measures are 
being further refined. (Hobart et al. 2001b)
Good responsiveness of the Barthel index and FIM in stroke and SCI, and 
the satisfactory properties of the self-report Barthel index, GHQ-28 and 
HADS in rehabilitation (Chapter 3), means that these measures can be used 
in randomised controlled trials (RCT) of rehabilitation interventions. Not all 
rehabilitation units have the resources to perform trials of this calibre, but 
many centres could perform observational studies to examine the effect of 
rehabilitation practices in different settings. (Wade 1999b) Whilst RCTs are 
the gold standard for all medical interventions, observational studies do have 
a role to play. Observational studies have been used to identify areas 
deserving of further study, to facilitate long-term follow-up of patients, 
(possibly after unblinding after an RCT) and to study interventions already in 
clinical practice, where their would be ethical problems in randomising 
patients to a control group. (Black 1996)
The measures of emotional wellbeing, depression and anxiety used in 
Chapters 3 and 4, the GHQ-28 and HADS, have had limited psychometric 
evaluation in rehabilitation settings. As with the Barthel index and FIM, these 
measures also need to be examined in other neurological rehabilitation 
settings and with other patient groups. This large-scale collection of data 
from patients in neurological rehabilitation could be facilitated by more
widespread use of outcome measurement data collection through the use of 
integrated care pathways as discussed in Chapter 1. (Lowe 1998)
As the patient is the best placed person to evaluate an intervention, a patient 
based outcome measure might be thought to be the best method of 
recording that patient s evaluation of change. In most situations this would be 
the case, but there are some patient groups in neurological rehabilitation 
practice where the patient’s opinion of his or her health status is difficult to 
ascertain successfully. For patients in vegetative or minimally responsive 
states, for instance, or patients with profound communication or cognitive 
impairments, obtaining the patient’s opinion presents substantial challenges.
The effect of cognitive impairment (memory, reasoning or attention), visual or 
speech impairment, or the combination of these, on patients’ responses to 
outcome measures has not been fully explored. Even patients with 
neurological lesions that might not be considered to cause cognitive 
impairment, such as brainstem haemorrhages or infarcts, can be 
demonstrated to have reduced cognition. (Garrard et al. 2002) Trials that 
include patients with these impairments need careful design, possibly with 
consideration of the use of patient proxy reports. (Cusick et al. 2000) Patient 
proxy reports have been shown to be accurate when collecting data on 
physical function, (Duncan et al. 2002) but less so with pain or emotional 
distress. (Andresen et al. 2001) It may be worthwhile to collect this data 
routinely in certain clinical scenarios, for example, when monitoring patients
with progressive conditions such as MS, to examine the relationship between 
patients’ opinions and those of their carers, particularly in the area of 
emotional wellbeing. This information could then be used to inform decision 
making on an individual patient’s treatment if he or she subsequently 
developed cognitive impairment.
With the introduction of classical psychometric methods into healthcare 
measurement over the last 20 years, there has been an increase in the 
number of centres evaluating and developing outcome measures. (Hobart 
and Thompson 2002) One of the limitations of classical psychometric 
techniques is the interdependence between the properties of the measure 
and the sample itself. (Hobart 2002) This was illustrated in Chapter 2, where 
treatment efficacy was linked to item responsiveness. Newer methods of 
analysis, such as item response theory and Rasch analysis, have facilitated 
a more comprehensive evaluation of measures used routinely in 
rehabilitation practice. (Grimby et al. 1996) These methods generate 
“sample-free” item calibrations of the items in a measure, which allows a 
measure to be evaluated without the characteristics of the sample impacting 
on the properties of the measure.
Such sample-free items can then be collated into item banks, which are 
repositories of calibrated items that allow measures to be developed to suit 
the characteristics of the sample under review. Using banks of well- 
calibrated items means that fewer items are required to measure a patient’s
ability in relation to other patients with similar conditions. This is the basis of 
computer adaptive testing (CAT) where a patient’s response to a particular 
item influences the choice of subsequent items. The use of CAT is already 
widespread in education and psychological testing to obtain an individual’s 
position in relation to their peers for a given test. This work is already being 
used in health outcome measurement where a CAT version of the SF-36 is 
available on the Internet to allow patients to monitor their own health. This is 
likely to be the future of measurement in neurological rehabilitation in the 21st 
Century. (Ware, Jr. 2003)
5.4 Conclusion
The evidence base for neurological rehabilitation must be strengthened by 
well-designed clinical trials of therapeutic interventions. In order to achieve 
this, two objectives must be met. First, outcome measures that can 
accurately evaluate the intervention must be used in trials. Second, trials 
need to focus on the underlying constructs that lead to disability -  
impairments, activity limitations and participation restrictions -  and try to 
influence them, or at least reduce the impact they have on the individual. 
Effective interventions can then be used by the multidisciplinary team with 
individual patients in a rehabilitation programme, with the outcome of these 
interventions routinely measured and audited.
If these objectives can be met in rehabilitation practice then healthcare 
resources will be used more efficiently, service delivery will be improved and, 
most importantly, the journey of a patient through the rehabilitation process 
will be enhanced.
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Appendix 1 Self-report Barth el index
These are some questions about your ability to look after yourself 
They might not seem to apply to you; please answer them all 
Tick one box in each section
In the bath or shower, do you
manage on your own?
need help getting in and out?
need other help?
never have a bath or shower?
need to be washed in bed?
Do you climb stairs at home
without any help?
with someone carrying your frame?
with someone encouraging you?
with physical help?
not at all?
don’t have stairs?
Do you get dressed
without any help? 
just with help with buttons? 
with someone helping you most of the time?
Do you walk indoors
without any help apart from a frame?
with one person watching over you?
with one person helping you?
with more than one person helping you?
not at all?
Or do you use a wheelchair independently?
Do you move from bed to chair
on your own? 
with a little help from one person? 
with a lot of help from one or more people?
not at all?
Do you eat food
without any help? 
with help cutting food or spreading butter?
with more help?
Do you use the toilet or commode
without any help? 
with some help but can do something?
with quite a lot of help?
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Do you brush your hair and teeth and wash your 
face
without help? 
with help?
Are you incontinent of urine
never?
less than once a week?
less than once a day?
more often?
Or do you have a catheter managed for you?
Do you soil yourself
never?
occasional accident? 
all the time?
Or do you need someone to give you an enema?
Appendix 2 General Health Questionnaire
We should like to know if you have had any medical complaints and how 
your health has been, over the past few weeks. Please answer all the 
questions on the following page simply by marking the answer which you 
think most nearly applies to you. Remember that we want to know about 
present and recent complaints, not about those you have had in the past.
Have you recently Better Same Worse Much
than as than worse
Been feeling perfectly well and in good 
health?
usual
1
usual
2
usual
3
than usual 
4
Been feeling you need a good tonic? 1 2 3 4
Been feeling run down and out of sorts? 1 2 3 4
Felt that you are ill? 1 2 3 4
Been getting any pains in your head? 1 2 3 4
Been getting a feeling of tightness or 
pressure in your head? 1 2 3 4
Been having hot or cold spells? 1 2 3 4
Have you recently
Lost much sleep over worry?
Had difficulty staying asleep once you were 
off?
Feel constantly under strain?
Been getting edgy and bad-tempered?
Been getting scared or panicky for no good 
reason?
Found everything getting on top of you?
Been feeling nervous and strung-up all the 
time?
Better
than
usual
Same Worse 
as than
usual
2
2
2
2
2
2
Much 
worse 
usual than usual
3
3
3
3
3
3
3
4
4
4
4
4
4
4
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Have you recently Better Same Worse Much
than as than worse
usual usual usual than usual
Been managing to keep yourself busy and 
occupied? 1 2 3 4
Been taking longer over things you do? 1 2 3 4
Felt on the whole you were doing things well? 1 2 3 4
Been satisfied with the way you’ve carried out 
tasks? 1 2 3 4
Felt that you were playing a useful part in 
things? 1 2 3 4
Felt capable of making decisions about 
things? 1 2 3 4
Been able to enjoy your normal day to day 
activities? 1 2 3 4
Have you recently
Been thinking of yourself as a worthless 
person?
Felt that life is entirely hopeless?
Felt that life isn’t worth living?
Thought of the possibility that you might make 
away with yourself?
Found at times that you couldn’t do anything 
because your nerves were too bad?
Been wishing you were dead and away from 
it all?
Found that the idea of taking your own life 
kept coming into your mind?
Not at 
all
No
more
than
usual
Rather
more
than
usual
Much 
more than 
usual
4
4
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Appendix 3 Hospital Anxiety and Depression Scale
These are some questions about how you are feeling. Please answer them 
all; tick one box in each section.
1 feel tense or “wound up”
most of the time 
a lot of the time 
from time to time, occasionally
not at all
1 still enjoy the things 1 used to enjoy
definitely as much
not quite so much
only a little
hardly at all
1 get a sort of frightened feeling as if something awful is about to happen
definitely and quite badly
yes, but not too badly
a little, but it doesn’t worry me
not at all
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I can laugh and see the funny side of things
as much as always 
not quite so much now 
definitely not so much now 
not at all
Worrying thoughts go through my mind
a great deal of the time 
a lot of the time 
from time to time, but not too often 
only occasionally
I feel cheerful
not at all 
not often 
sometimes 
most of the time
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1 can sit at ease and feel relaxed
definitely 
usually 
not often 
not at all
1 feel as if 1 am slowed down
nearly all the time 
very often 
sometimes 
not at all
1 get a sort of frightened feeling like butterflies in the stomach
not at all 
occasionally 
quite often 
very often
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I have lost interest in my appearance
definitely
I don’t take as much care as I should 
I may not take quite as much care 
I take just as much care as ever
I feel restless as if I have to be on the move
very much indeed 
quite a lot 
not very much 
not at all
I look forward with enjoyment to things
as much as I ever did 
rather less than I used to 
definitely less than I used to 
hardly at all
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I get sudden feelings of panic
very often indeed 
quite often 
not very often 
not at all
I can enjoy a good book or radio or TV programme
often 
sometimes 
not often 
very seldom
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Appendix 4: Impact on Work Questionnaire
We are interested in how each of the following impacts on your ability to 
work. For each statement, please circle one answer that best describes your 
situation.
How much does Impact on your work (please circle)
Fatigue No at all A little Moderately Quite a bit Extremely
Balance No at all A little Moderately Quite a bit Extremely
Walking difficulties No at all A little Moderately Quite a bit Extremely
Visual problems No at all A little Moderately Quite a bit Extremely
Weakness No at all A little Moderately Quite a bit Extremely
Handwriting No at all A little Moderately Quite a bit Extremely
Pain No at all A little Moderately Quite a bit Extremely
Coordination No at all A little Moderately Quite a bit Extremely
Speech No at all A little Moderately Quite a bit Extremely
Swallowing No at all A little Moderately Quite a bit Extremely
Continence No at all A little Moderately Quite a bit Extremely
Concentration No at all A little Moderately Quite a bit Extremely
Memory No at all A little Moderately Quite a bit Extremely
Mood No at all A little Moderately Quite a bit Extremely
Travel to work No at all A little Moderately Quite a bit Extremely
Access at work No at all A little Moderately Quite a bit Extremely
Public attitudes No at all A little Moderately Quite a bit Extremely
237
